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Synaptic scaling is a form of homeostatic plasticity that initiates compensatory 
adaptations in synaptic strength to buffer chronic aberrant levels of activity within neural 
circuits. L-type voltage-gated Ca2+- channels (LTCCs) play a key role in the induction of this 
process as evident in the regulation of scaling mediated by LTCC signaling blockade with 
dihydropyridine antagonists. These agents, however, do not distinguish between the two LTCC 
subtypes CaV1.2 and CaV1.3 expressed in the brain. Outlined in Chapter 2, we investigated the 
unique roles of these LTCC subtypes and found that the deletion of CaV1.2 in excitatory neurons 
induced a significant increase in basal synaptic strength and surface expression of α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) whilst occluding TTX-
induced synaptic upscaling. By contrast, TTX-induced upscaling of miniature excitatory 
postsynaptic currents (mEPSCs) is lost in CaV1.3 deficient neurons, with no alterations in basal 
synaptic properties accompanying CaV1.3 deletion. In addition to mechanisms that induce 
synaptic scaling, we investigated whether previous homeostatic functional alterations reverse 
upon activity renormalization and whether a previous history of homeostatic scaling in networks 
altered subsequent homeostatic responses to chronic activity manipulations. We identified a 
novel “resetting” phase of synaptic scaling whereby homeostatic changes in synaptic strength 
revert to basal levels after activity renormalization. Furthermore, future synaptic scaling in 
response to the same, and even opposite, activity challenges is robustly suppressed by a prior 
history of scaling in hippocampal neurons. This history-dependent suppression is specific to 
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homeostatic plasticity as networks with prior scaling history showed no deficits in 
Hebbian forms of synaptic potentiation (cLTP). We further demonstrated that hippocampal 
neurons with a prior history of synaptic scaling exhibited widespread alterations in activity-
dependent transcriptional regulation despite normal engagement of activity-dependent signaling 
through the ERK/MAPK signaling pathway. Taken together, our data suggests that LTCC 
subtypes, CaV1.2 and CaV1.3, play nonredundant roles in the induction of synaptic scaling and 
that the history of homeostatic signaling in neural circuits plays a key role in shaping future 










Significance of synaptic plasticity within the brain 
Our experiences to an external environment, whether they are the warmth of a summer 
day, a stressful grizzly bear encounter, or a delightful Omakase lunch, all emerge from neural 
representations encoded by specific circuits in the brain. While stereotyped connections of 
specific neuron types are defining features of neural circuits, the ability of those connections to 
become stronger or weaker, or remodeled after different experiences allows us the ability to 
adapt successfully in a changing environment. This remodeling of neural connections is referred 
to as “synaptic plasticity,” and is one of the most fascinating characteristics of the mammalian 
brain because it allows neural activity generated by experience to shape neural circuit 
architecture and thereby neural representations of thoughts, feelings, and behavior. Indeed, 
intense research over the last 50 years has revealed a central role for synaptic plasticity in neural 
development (Chen & Tonegawa, 1997), learning and memory (Neves et al., 2008; Maren, 
2003), and the etiology of several neuropsychiatric disorders (Lau & Zukin, 2007; Nanou & 
Catterall, 2018). Thus, elucidating the underlying molecular mechanisms of synaptic plasticity in 
a variety of model organisms and brain regions is critical for understanding the neural basis of 
normal healthy and pathological brain function.
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Given the diverse roles for synaptic plasticity, it is not surprising that many distinct forms 
have been formally described that differ in their functional role, temporal dynamics, and 
underlying molecular mechanism. Emerging from this heterogeneity of synaptic remodeling 
mechanisms is one of the major conundrums in Neuroscience – How do all these distinct forms 
of synaptic plasticity work in concert to maintain proper brain function? This question becomes 
exceedingly complex because the potentiation or depression of synaptic neurotransmission by 
activity can happen within very wide temporal domains, ranging from milliseconds to days and 
presumably years for long-term memory (Zenke et al., 2017; Zenke & Gerstner, 2017). As such, 
a major factor distinguishing between different forms of synaptic plasticity is whether functional 
changes are relatively transient (short-term plasticity; milliseconds to minutes) or durable (long-
term plasticity; hours to years). 
 
Short-term synaptic plasticity 
 At chemical synapses, an action potential propagates down the axon and activates 
specific voltage-gated Ca2+ channels (VGCCs) at the axon terminal, the presynaptic region of the 
synaptic connection between neurons. The ensuing influx of Ca2+ ions through VGCCs trigger 
the rapid release of synaptic vesicles containing neurotransmitter, which diffuse a short distance 
before being detected by receptors on the postsynaptic cell. Unbound neurotransmitters in the 
synaptic cleft are either degraded by specific enzymes (Fon & Edwards, 2001) or recycled by 
specific neurotransmitter transporters (Murphy-Royal et al., 2017), preventing sustained 
postsynaptic stimulation after neurotransmitter release. Ultimately, presynaptic signaling elicits 
changes in ion permeability in the postsynaptic neuron leading to postsynaptic currents (PSCs) 
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and postsynaptic potentials (PSPs) that are integrated with other signaling to alter postsynaptic 
output. 
 The process described above is subject to several forms of dynamic modulation on the 
order of milliseconds to minutes. Strengthening of the postsynaptic response following 
presynaptic tetanic stimulation, or short-term synaptic enhancement (STE) comes in many 
different flavors and its four components are categorized based on the synaptic efficacy decay 
time constants: fast-decaying facilitation (F1; tens of milliseconds), slow-decaying facilitation 
(F2; hundreds of milliseconds), augmentation (AUG; thousands of milliseconds), and post-
tetanic potentiation (PTP; tens of seconds) (Fisher et al., 1997). Genetic, pharmacological, and 
behavioral evidence from multiple model systems including intracellular recordings in Aplysia 
(Sánchez & Kirk, 2000), miniature endplate potential (MEPP) recordings in rat (Nussinovitch & 
Rahamimoff, 1988) and frog (Zengel & Magelby, 1980) neuromuscular junction (NMJ), and 
paired whole-cell patch recordings in central synapses of hippocampal slices (Stevens et al., 
1994) indicate that these forms of STE are highly conserved. In parallel to enhancement, 
repetitive activation can also lead to short-term synaptic depression which is largely thought to 
be due to the depletion of vesicles within the readily releasable pool (Betz, 1970). Given that 
presynaptic stimulation can result in either short-term enhancement or depression, an obvious 
question arises – what are the underlying deterministic molecular mechanisms? Since these 
seminal studies, three quantal parameters have been characterized and are now commonly used 
to define key properties of synaptic transmission: 1) the maximum number of vesicles released 
by an AP or the number of functional release sites (n), 2) the probability of vesicular release (p), 




The role of calcium in short-term plasticity 
The crucial role of calcium in STE and the residual Ca2+ hypothesis was first proposed in 
the landmark paper of Katz and Miledi (Katz & Miledi, 1968). They proposed that short-term 
facilitation at the NMJ is induced by residual calcium after nerve stimulation which they tested 
using a paired-pulse stimulation paradigm and a Ca2+-free ringer solution. Upon removal of 
external Ca2+ during the initial conditioning pulse, Katz & Miledi observed no significant short-
term facilitation at NMJ synapses despite Ca2+ being present during the secondary test pulse. 
This result suggested that there exists some amount of calcium at the nerve terminal after the 
initial conditioning pulse that persists and interacts with Ca2+ influx from the second test pulse 
and that the increased Ca2+ levels is responsible for the facilitation of synaptic transmission. 
Subsequent studies confirmed the role of residual Ca2+ in F1, F2 (Kamiya & Zucker, 1994), 
AUG (Magelby & Zengel, 1976; Delaney et al., 1994), and PTP (Kretz et al., 1982; Swandulla et 
al., 1991). 
Upon further investigation of the original residual Ca2+ model, novel studies confirmed 
the necessity of expanding it to incorporate both spatial and temporal characteristics of Ca2+ ion 
concentrations; dubbed the spatiotemporal model. Numerous studies have implicated the 
existence of transient microdomains of elevated Ca2+ upon AP arrival at the presynaptic terminal 
(Llinás et al., 1992; Sugimori et al., 1994; Berridge, 2006), and that there is a dramatic drop off 
in concentration of the surrounding area within the nerve terminal. Additionally, even a single 
open VGCC generates a discrete influx of Ca2+ centered on its pore (Chad & Eckert, 1984). 
Collectively, these two models indicate that short-term synaptic plasticity is reliant on the timing 




Long-term synaptic plasticity 
 In contrast to more transient modifications of synaptic neurotransmission, it is widely 
believed that experience can also profoundly modify subsequent behaviors through long-lasting 
alterations of synaptic strength. Experience is encoded within the brain as complex events of 
spatiotemporal patterns of activity in a large ensemble of neurons, or neural circuits. Information 
is stored in the brain when activity within a circuit results in long-lasting changes in the pattern 
of synaptic weights. This idea was further refined by Donald Hebb who postulated that 
associative memories are formed in the brain through the process of strengthening synaptic 
connections when presynaptic activity correlates with postsynaptic firing (Hebb, 1949). 
Moreover, the anticorrelation is thought to weaken synaptic connections and result in failure to 
form the specific associative memory. This form of synaptic plasticity, predicated on the 
detection of two coincident events, has since been termed “Hebbian” synaptic plasticity and has 
been intensely studied for its role in the formation of associative memories such as those 
established by Pavlovian classical conditioning (Pavlov, 1927). 
 The first experimental evidence for long-lasting activity-dependent changes in synaptic 
strength emerged in the 1970s from the landmark studies by Bliss, Lomo and their colleagues in 
Per Anderson’s laboratory (Bliss & Lomo, 1973; Bliss & Gardner-Medwin, 1973). These 
studies, conducted in anesthetized rabbits, demonstrated robust potentiation of postsynaptic 
responses recorded from granule cells in the dentate gyrus after repetitive stimulation of the 
afferent perforant pathway. This potentiation was determined by the increases in amplitude of the 
population excitatory post-synaptic potential (EPSP) and increases in the amplitude and latency 
of the population spike. In contrast to the fast-decaying kinetics of STE, the synaptic potentiation 
reported by Bliss and Lomo was far more durable, lasting as long as 10hrs (Bliss & Lomo, 1973) 
6 
 
to 3 days (Bliss & Gardner-Medwin, 1973) after induction. This phenomenon, now termed long-
term potentiation (LTP), has been the subject of intense investigation because it is believed to 
capture important aspects of the cellular mechanism of long-term memory formation. 
Importantly, LTP is complemented by several forms of long-term depression (LTD), enabling 
bidirectional malleability within neural circuits. Heterosynaptic LTD was first observed in 1977 
where Lynch et al. reported a generalized depression of synaptic efficacy after LTP induction in 
one set of synapses (Lynch et al., 1977) and has been reliably observed in the dentate gyrus 
(Abraham & Goddard, 1983) and CA1 (Abraham & Wickens, 1991) regions of the hippocampus.  
Furthermore, it has become increasingly clear that LTP and LTD are only terms that describe 
classes of synaptic plasticity; the underlying molecular mechanism vary depending on the 
organism and the circuits in which they function and the specific induction stimulus protocol 
used. 
A defining feature of LTP at many synapses is its reliance on N-methyl-D-aspartate 
receptors (NMDARs), a ligand-gated ion channel that requires simultaneous binding of 
glutamate and postsynaptic membrane depolarization to achieve maximal conductance and is 
thus thought to serve as a molecular coincidence detector. NMDA receptors provide a molecular 
basis for encoding correlative activity between neurons through the detection of two temporally 
close and spatially distributed signaling events, a key feature in Hebbian plasticity. Moreover, 
pharmacological disruption of NMDAR-signaling with APV (Morris et al., 1986) or MK-801 
(Shapiro & Caramanos, 1990) inhibits LTP induction and impairs hippocampal-dependent 
spatial learning. Importantly, there is also sufficient evidence of synaptic LTP induction that 
does not require NMDAR activation. For example, 100 µM APV treatment during conditioning 
stimulus had no effect on the long-lasting potentiation of EPSPs recorded from layer II/III 
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neurons of kitten visual cortex (Komatsu et al., 1991). Additional evidence of NMDAR-
independent LTP can be found within the hippocampus, where mossy fiber projections onto CA3 
pyramidal neurons exhibit a presynaptic form of LTP that is independent of NMDAR activation 
(Dahl et al., 1990). Interestingly, it has been shown that within the same synapses in CA3-CA1 
hippocampal neurons, varying stimulation protocols result in distinct forms of LTP; high-
frequency stimulation (HFS) (Harris et al., 1984; Coolingridge et al., 1983; Morris et al., 1986) 
or theta-burst stimulation (TBS) (Nguyen & Kandel, 1997) induces NMDAR-dependent LTP 
whereas 200Hz tetanic stimulation (Grover & Teyler, 1990; Grover, 1998) or activation of 
metabotropic G-protein coupled receptors induces NMDAR-independent LTP. 
We now know that the complexity of long-term plasticity extends past the immediate 
output of strengthening or weakening of synapses. As with short-term plasticity, LTP and LTD 
have also been dissected temporally with conclusive evidence indicating that these phenomena 
are multiphasic. It is widely accepted that LTP can be divided into at least three different phases: 
early LTP (E-LTP), intermediate LTP (I-LTP) and late LTP (L-LTP). E-LTP and L-LTP were 
first distinguished based on the observations that several high-frequency stimulus trains 
produced larger and more durable potentiation than a single stimulus train, an effect that was 
abolished in the presence of protein synthesis inhibitors (Krug et al., 1984; Frey et al. 1988). This 
late stage of LTP was later found to also depend on D1 dopamine receptors (Huang & Kandel, 
1995; Frey et al., 1991), cAMP (Nguyen et al., 1994), PKA (Matthies & Reymann, 1993; Huang 
& Kandel, 1994; Abel et al., 1997), ERK (Winder et al., 1999; Schafe et al., 2008), and CREB 
phosphorylation (Impey et al., 1996). I-LTP was later described to require PKA but not protein 
synthesis (Winder et al., 1998). Collectively these data suggest that unique patterns of 
stimulation evoke multiple phases of long-lasting synaptic plasticity that can be distinguished by 
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both their persistence and underlying molecular mechanisms. In this respect, parallels can be 
drawn between LTP and STE in that both forms of plasticity exhibit unique temporal variants 
that are mechanistically distinct. This feature also seems to be highly conserved, as a variety of 
model synapses in a range of organisms exhibit distinct forms of enduring plasticity that persist 
for varying periods depending on the pattern of stimulation delivered for induction; long-term 
facilitation (LTF) in Aplysia californica following repeated spaced shocks or 5-HT pulses last 
>24hrs (Walters et al., 1983; Buonomano et al., 1990), LTF of miniature excitatory junctional 
potentials (mEJPs) in Drosophila melanogaster larvae NMJ with >5Hz stimulation persists for 
tens of seconds (Jan & Jan, 1978), and LTF of EJPs in the proximal muscle fibers of 
Procambarus clarkii elicited following 10 minute tetanic train at 20Hz last >1hr (Beaumont et 
al., 2001). 
 
The role of calcium in long-term plasticity 
 Alike STE, the induction of LTP mechanisms is heavily reliant on Ca2+-mediated 
signaling. Beyond its presence during neurotransmission, Ca2+ role as a second messenger is 
crucial in triggering complex signaling cascades required for both LTP and LTD. The 
directionality of plasticity is determined by three characteristics of Ca2+: the amplitude, duration, 
and location, reviewed in (Evans et al., 2015). The calcium amplitude hypothesis, also known as 
the two-threshold hypothesis, was the first proposed (Lisman, 1989; Artola et al., 1990; Artola & 
Singer, 1993). It posited that a moderate but sufficient Ca2+ concentration is necessary for LTD 
and that higher levels are necessary for LTP. Evidence of this has been shown with imaging 
studies of Ca2+ concentration in layer 2/3 pyramidal cells of rat visual cortical slices during 
application of either HFS or LFS. It has been shown that calcium peak signals were the highest 
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during the HFS protocol and lower during the LFS protocol which resulted in LTP and LTD, 
respectively, synaptic changes that were completely abolished upon the addition of Ca2+ 
chelators (Hansel et al., 1996). The two-threshold hypothesis was more directly tested by 
manipulating extracellular calcium concentration in the hippocampus during frequency-
dependent plasticity. Lowering extracellular calcium induced LTD in CA1 pyramidal cells 
despite using a stimulation protocol that previously elicited LTP (Mulkey & Malenka, 1992). 
Spike-timing dependent plasticity (STDP) provides further evidence for the Ca2+ amplitude 
model. LTP is elicited when pre-synaptic stimulation precedes post-synaptic action potential 
whereas LTD is induced when post-synaptic AP precedes pre-synaptic stimulation (Bi & Poo, 
1998). The former was demonstrated to trigger a higher elevation in calcium concentration 
within single spines on basal dendrites of neocortical layer 5 pyramidal neurons (Koester & 
Sakmann, 1998). 
This initial hypothesis was built upon with observations that Ca2+ mediated signaling is 
not as simple as just high or low concentration. The duration of calcium transients also plays a 
critical role in determining whether neural circuits undergo LTP or LTD. Evidence of this 
phenomenon emerged from Ca2+ uncaging experiments that allowed experimenters precise 
temporal control of Ca2+ elevation. Uncaging of a calcium compound, nitrophenyl-ethylene 
glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid, in CA1 pyramidal neurons, Yang et 
al., demonstrated that LTP can only be triggered by a brief and relatively high magnitude 
(>10µM for a few seconds) of Ca2+ elevation whereas LTD is induced by a prolonged and 
modest (~750nM for 1 minute) rise (Yang et al. 1999).  
Lastly, there is evidence that the location of calcium entry also determines the direction 
of plasticity. Indication that the source of calcium is vital stems from experimental evidence that 
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demonstrates channel specificity during LTP and LTD. For example, within the striatum, Ca2+ 
influx through NMDARs is necessary for LTP whereas through L-type voltage gated calcium-
channels (VGCCs) is necessary for LTD (Fino et al., 2010; Shindou et al., 2011). In contrast, 
within the hippocampus, NMDAR-mediated Ca2+ signaling is required for both LTP and LTD 
while L-type VGCCs is only responsible for the latter (Bi & Poo,1998). In addition to brain 
region differences, the cellular location of calcium influx is also crucial. Liu and colleagues 
demonstrated that TBS induces LTD in CA1 neurons of rat hippocampal slices by selectively 
blocking synaptic NMDARs with MK-801 (Liu et al., 2013). This piece of data suggests that the 
resulting plasticity is directly linked to which cohort of NMDARs are activated; activation of 
post-synaptic NMDARs induces LTP and activation of extrasynaptic NMDARs induces LTD 
despite equal electrical stimulation. Collectively, the accumulation of data over the span of 
several decades reveals the essential role of Ca2+ signaling in both short-term and long-term 
forms of plasticity although it has been suggested that glutamate binding to NMDARs alone and 
not Ca2+ influx is sufficient to induce LTD (Navabi et al., 2013). Moreover, these conclusions 
only scratch the surface. It is still unclear how calcium signaling through different calcium 
channels, in different brain regions, and even different compartments of the same neuron can 
have such profoundly different outcomes in synaptic efficacy. 
 
Homeostatic control of neuronal excitability 
 Thus far, I have discussed forms of synaptic plasticity that are thought to play a role in 
information processing or storage in neural circuits. To provide consistent and stable 
representations, neural circuits must offset their malleability, crucial for information storage, 
with mechanisms that actively promote stability of network activity to maintain circuit function 
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in a useful dynamic range. This innate “homeostatic” control is not unique to the human brain as 
it has been a central concept of physiological systems, first described by Claude Bernade as ‘la 
fixité du milieu intérieur’, or the constancy of the internal environment (Claude, 1878). This 
concept was later coined, homeostasis (Cannon, 1926; Cannon, 1929), and has become a 
fundamental theme in modern biology that describes the tendency of readjustments such that an 
equilibrium or a steady state is achieved. Early studies of homeostatic mechanisms were 
primarily focused on the stability of blood constituents (Henderson & Haggard, 1918; Austin et 
al., 1922; Perlman, 1977) with further evidence of homeostasis developed later in studies of 
muscle excitability observed during denervation super sensitivity (Axelsson & Thesleff, 1959). 
Although originally proposed to account for excitability changes in muscle, it is now clear that 
homeostatic mechanisms are pervasive in the central nervous system and are key to maintain 
proper functioning in neural circuits. 
 
Homeostatic synaptic scaling 
 The first indication that central synapses exhibit homeostatic regulation was provided in 
1998, in a now classic paper from Turrigiano and colleagues (Turrigiano et al., 1998). In this 
study, networks of cortical excitatory neurons exhibited bidirectional synaptic adaptations in 
response to long-term changes in activity. They showed that chronic (48hrs) activity silencing, 
via inhibition of voltage-gated Na+ channels with tetrodotoxin (TTX), induced a homeostatic 
increase in miniature excitatory post synaptic current (mEPSC) amplitudes, a measure of basal 
synaptic function (Katz & Miledi, 1963; Colomo and Erulkar, 1968; Brown et al., 1979). 
Conversely, chronic (48hr) hyperactivation of neuronal networks, via blockade of gamma-
Aminobutyric acid A receptors (GABAA), resulted in a decrease in mEPSC amplitude 
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(Turrigiano et al., 1998). This homeostatic adaptation in response to deviations in firing rate was 
further found to be multiplicative in nature; the distribution of mEPSC amplitudes appeared to 
shift by a constant “scaling” factor, which has led the field to dub this form of homeostatic 
plasticity, “synaptic scaling.” These early findings initiated a novel field of neuroscience devoted 
to understanding this and other forms of homeostatic synaptic plasticity (HSP), based on the 
hypothesis that homeostatic adjustments of synaptic properties play a key role in stabilizing 
neural firing rates in the face of dynamic changes in neural circuits. 
 Synaptic scaling is the most heavily studied homeostatic mechanism at central synapses, 
but it is now evidently clear that scaling only represents one of many processes that neurons 
utilize to stabilize activity levels. Neurons also homeostatically regulate its intrinsic excitability 
(Marder & Goaillard, 2006; Zhang & Linden, 2003), ion conductance (Golowasch et al., 1999; 
Frank, 2014) and inhibitory synaptic transmission (Kilman et al., 2002; Swanwick et al., 2006). 
In addition, while synaptic scaling is most likely driven by changes in neural firing rate, other 
forms of HSP have been describe that are tuned to local synaptic drive (Sutton et al., 2006; 
Branco et al., 2008; Jakawich et al., 2010a; Lindskog et al., 2010). Synaptic scaling can be 
distinguished from these “local” HSP processes as well as from Hebbian forms of plasticity by 
three main characteristics. First, synaptic scaling is thought to occur in a global, cell-
autonomous, and multiplicative manner that serves to adjust cell excitability while retaining 
synapse-specific information previously stored through other forms of plasticity such as LTP or 
LTD (Turrigiano & Nelson, 2000; Turrigiano & Nelson, 2004; Nelson & Turrigiano, 2008; 
Turrigiano, 2008; Rabinowitch & Segev, 2008; Turrigiano, 2012). While many studies, some of 
which are listed here, have demonstrated relatively uniform shifts in synaptic weights during 
scaling, a recent study (Hanes et al., 2020) has suggested a novel “divergent scaling” of weaker 
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synapses relative to stronger synapses on the same neuron, a finding that complicates the 
canonical view of homeostatic scaling as purely multiplicative in nature. 
 A second characteristic feature of synaptic scaling is its slow time course. While activity 
manipulations generally alter network function immediately, the compensatory synaptic 
adaptations that ensue require at least 18 hours to first emerge (Turrigiano et al., 1998; Watt et 
al., 2000; Sutton et al., 2006; Ibata et al., 2008). In contrast to synaptic scaling, there is a wealth 
of evidence of other existing HSP mechanisms induced by changes in synaptic drive (instead of 
firing rate) and act on more rapid timescales. A brief (~3hrs) blockade of NMDARs coincident 
with AP blockade scales up synaptic strength orders of magnitudes faster than AP blockade 
alone (Sutton et al., 2006; Jakawich et al., 2010a; Henry et al., 2012). Additionally, 
pharmacological inhibition of glutamate receptors with a noncompetitive blocker, GYKI 53655, 
of mossy fiber synapses in the mouse cerebellum rapidly (minutes) modulated presynaptic 
exocytosis, a form of presynaptic homeostasis (Delvendahl et al., 2019). Rapid forms of HSP 
have also been studied in the Drosophila neuromuscular junction (NMJ) where the blockade of 
postsynaptic AMPARs induced an acute homeostatic increase in presynaptic quantal content 
within minutes to offset the decrease in postsynaptic drive (Frank et al., 2006). Although 
synaptic scaling and local HSP are clearly unique with distinct underlying mechanisms, the 
existence of both forms of homeostatic plasticity suggest that neural circuits can maintain 
stability during activity perturbations across a wide temporal range. Likely, forms of HSP 
mechanisms exist on a spectrum varying from rapid to long timescales and its induction is 




A third characteristic of synaptic scaling that has been intensely studied, is the 
postsynaptic mechanisms required for the regulation of synaptic efficacy. There is, however, 
extensive research detailing homeostatic changes in presynaptic function in response to activity 
perturbations during synaptic scaling (Murthy et al., 2001; Burrone et al., 2002; Thiagarajan et 
al., 2005; Jakawich 2010). A multitude of studies in varying model systems and varying 
pharmacological manipulations have demonstrated adaptations of postsynaptic glutamate 
receptors after activity perturbation. Hyperactivation of hippocampal networks with picrotoxin 
resulted in the NMDAR-dependent removal of GluA1 at synapses (Lissin et al., 1998). This 
finding was corroborated in cultured spinal neurons where decreases in glutamatergic (APV + 
CNQX) or GABAergic (picrotoxin + strychnine) signaling resulted in the homeostatic 
accumulation and loss of GluA1, respectively (O’Brien et al., 1998). Additionally, silencing of 
visual cortical neurons with TTX (Weirenga et al., 2005) or with monocular TTX injections 
(Gainey et al., 2009) both resulted in the robust increase in GluA2 expression. Together, these 
findings suggest that postsynaptic glutamate receptor protein expression levels are 
homeostatically regulated during neuronal activity perturbation. 
An immense amount of experimental attention has been focused on homeostatic 
postsynaptic mechanisms, but an equal amount of effort has been placed in understanding 
presynaptic mechanisms and have branched off into an entirely new field of study, presynaptic 
homeostatic plasticity (PHP). Distinct from synaptic scaling, accumulating evidence within 
studies using the model system, Drosophila melanogaster, indicate a homeostatic response upon 
pharmacological inhibition of glutamatergic signaling, akin to alterations of synaptic drive 
studies in central synapses (Sutton et al., 2006; Aoto et al., 2008; Hou et al., 2008; Jakawich et 
al., 2010; Lindskog et al., 2010). An acute perturbation with a GluR antagonist, philanthotoxin-
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433 (Frank et al., 2006), or sustained genetic glutamate receptor impairment (GluRIIA ablation; 
Petersen et al., 1997) induces a homeostatic increase in neurotransmitter release. This precise 
compensation has led to the hypothesis that PHP involves a retrograde, trans-synaptic signaling 
system (Delvendahl & Müller, 2019). These studies also suggest that functional compensations 
at synapses are not necessarily limited to regulation of postsynaptic protein expression and that 
both pre- and postsynaptic regions are subject to activity-dependent alterations. 
 
Synaptic scaling in the pathological brain 
Evidence amassed over the past decade have indicated the significance of homeostatic 
plasticity mechanisms in both healthy and pathological brain function. Dysfunction of HSP has 
been implicated in a growing number of neurological disorders, a topic that has been reviewed 
extensively elsewhere (Wondolowski & Dickman, 2013). For example, loss of the FMR protein 
(FMRP) causes Fragile X Syndrome, an inherited neurodevelopmental disorder characterized by 
autism, intellectual disability, and hyperactivity.  FMRP is also critical for the expression of 
retinoic acid-mediated homeostatic increases in AMPAR expression (Soden & Chen, 2010; Sarti 
et al., 2013) and homeostatic changes in intrinsic excitability driven by chronic changes in 
network activity (Bülow et al., 2019). Likewise, Rett syndrome is caused by loss of MeCP2, and 
MeCP2 has been shown to be necessary for homeostatic synaptic upscaling (Blackman et al., 
2012; Qiu et al., 2012; Zhong et al., 2012; Della Sala & Pizzorusso, 2014).  Tuberous sclerosis, a 
neurodevelopmental disorder caused by hyperactivation of the mTORC1 pathway, is also 
associated with dysregulated homeostatic plasticity (Henry et al., 2012; Bateup et al., 2013). 
Finally, we recently examined the role of retinoic acid induced 1 (RAI1) in synaptic scaling, loss 
of which causes Smith Magenis Syndrome, and found that it played a critical role in suppressing 
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synaptic scaling during normal levels of network activation (Garay et al., 2020).  Taken together, 
these studies suggest that dysregulated synaptic scaling is a pathological hallmark of numerous 
neurodevelopmental disorders. 
In addition to neurological disorders, synaptic scaling has also gained traction as a 
potential target mechanism for neuropsychiatric treatments. Recent studies of ketamine, a 
NMDAR antagonist, and lithium, a common treatment for depression and bipolar disorder, 
respectively, have reported to trigger synaptic scaling-like alterations in synaptic efficacy. Acute 
(1-3hrs) application of ketamine increases mEPSC amplitudes globally whereas chronic (10-11 
days) treatment with lithium results in a marked downscaling of synaptic strength (Kavalali & 
Monteggia, 2020). Although ketamine and lithium treatments have very different mechanisms of 
action, both appear to initiate scaling of synaptic strength, albeit, in opposite directions. 
Synaptic scaling has also been found to play a role in drug addiction. The majority of 
studies until recently have been focused on rapidly-inducing Hebbian forms of plasticity and its 
involvement in addiction-motivated behavioral and synaptic adaptations (Kauer & Malenka, 
2007). Regulation of AMPAR expression during LTP and LTD has also been implicated in drug-
seeking behaviors during cocaine re-exposure in the nucleus accumbens (Kourrich et al., 2007; 
Brebner et al., 2005; Anderson et al., 2008). More recently, upscaling of GluA1 and GluA2 
containing AMPARs in the nucleus accumbens has been proposed as a mechanism for the slowly 
developing and prolonged plasticity changes during cocaine withdrawal (Boudreau & Wolf, 
2005). 
Connections between homeostatic synaptic plasticity dysfunction and pathological brain 
function are only starting to be revealed. Importantly, the molecular mechanisms that link 
disorder phenotypes with defective HSP are far from fully understood, illustrating the need for 
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continued research into this area.  There is a general consensus, however, that defining those key 
points of molecular regulation will open up novel avenues for designing effective therapeutics 
against these disorders. 
 
Homeostatic synaptic plasticity is observed in many brain regions and neurotransmitter 
systems 
It is becoming increasingly clear that neurons, depending on type and brain region, 
exhibit and utilize many different plasticity tools to adapt to a wide variety of activity-dependent 
perturbations. Homeostatic plasticity phenotypes have been described in the hippocampus 
(Sutton et al., 2006), the cortex (Turrigiano et al., 1998), the spinal cord (Chub & O’Donovan, 
1998; Galante et al., 2001; Wenner, 2014; Gonzalez-Islas et al., 2018), the nucleus accumbens 
(Ishikawa et al., 2009; Sun and Wolf, 2009), the cerebellum (Iijima et al., 2009), the locus 
coeruleus (Cao et al., 2010), and the striatum (Azdad et al., 2009). It has also been heavily 
studied in a variety of neurotransmitter systems including glutamate (Turrigiano et al., 1998; 
Sutton et al., 2006; Goel et al., 2011), GABA (Bartley et al., 2008; Saliba et al., 2009; Keck et 
al., 2011), glycine (Ganser & Dallman, 2009), endocannabinoid (Kim & Alger, 2010), and 
dopamine (Azdad et al., 2009; Sun and Wolf, 2009). The flexibility HSP affords neurons allows 
for malleable neuronal circuits to learn and undergo ongoing plasticity while simultaneously 
buffer destabilizing forces. However, many challenges lie ahead in understanding the interplay 





The role of calcium in homeostatic synaptic plasticity 
Ca2+ has a particularly important role in excitable cells like neurons as an intracellular 
second messenger. At rest, the intracellular calcium concentration of most neurons fluctuates 
around 50-100nM and can transiently increase multiple magnitudes of orders higher during 
electrical activity (Berridge et al., 2000). Unsurprisingly, there exists a host of different buffering 
mechanisms which help stabilize the concentration of free calcium ions within cells. Intracellular 
Ca2+ buffers generally refer to members of the EF-hand protein family, proteins with a structural 
domain consisting of an α-helix–loop–α-helix motif of approximately 30 amino acids (Schwaller, 
2020). Hundreds (>600) of family members have been discovered with the prototypical Ca2+ 
sensor being calmodulin (CaM; Chin et al., 2000). Importantly, the majority of calcium buffers 
have dissociation constants for Ca2+ at least an order of magnitude higher than the average Ca2+ 
concentration at rest, indicating that these buffer mechanisms are generally in the unbound state 
(Schwaller, 2020). For this reason, Ca2+ is the ideal sensor candidate for electrical activity and 
has been theorized to be how neurons “sense” changes in intrinsic activity levels. 
In recent years, voltage-gated Ca2+ channels (VGCC) have gained considerable 
recognition for their potential role in homeostatic control of synapse function. VGCCs mediate 
voltage-dependent calcium entry and regulate activity-dependent processes such as 
neurotransmission, gene transcription, and intracellular signaling cascades (Murphy et al., 1991; 
Catterall, 2000; Zamponi et al., 2005; Lipscombe et al. 2013). This family of cation channels can 
be subdivided into several subfamilies based on their pharmacological and physiological 
properties: L-type (CaV1), T-type (CaV3), P/Q-type, R-type, and N-type (CaV2) (Catterall, 2000). 
P/Q/N channels of the CaV2 family have been shown to gate homeostatic changes in presynaptic 
function at hippocampal synapses driven by loss of postsynaptic excitatory synaptic drive 
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(Jakawich et al., 2010; Henry et al., 2018). Similarly, loss-of-function mutations in the 
Drosophila cacophony (cac) gene, the pore-forming α1 subunit of CaV2 channels, prevent the 
homeostatic increase in quantal content at the NMJ induced by pharmacological or genetic 
impairment of postsynaptic glutamate receptor function (Frank et al., 2006; Müller & Davis, 
2012). More recently, Ca2+ influx through P/Q-type, but not N-type VGCCs has been shown to 
mediate bidirectional homeostatic regulation of neurotransmitter release and size of synaptic 
vesicle pools in hippocampal neuron cultures (Jeans et al., 2017).  In addition to a role for P/Q/N 
channels in presynaptic forms of synaptic compensation, LTCCs are thought to be critical for 
encoding chronic changes in neuronal activity that drive synaptic scaling.   Several studies have 
demonstrated that the pharmacological blockade of LTCC signaling with dihydropyridines is 
sufficient to drive homeostatic upscaling of synaptic strength (Thiagarajan et al., 2005; Ibata et 
al., 2008; Henry et al., 2012) and block upscaling (Sokolova & Mody, 2008). Dihydropyridines, 
however, have several off-target effects and do not distinguish between the two major types of 
LTCCs expressed in the brain.  I address this issue using a genetic approach in Chapter 2. 
 
Calcium signaling during synaptic scaling 
Downstream of calcium ion entry, exists many Ca2+ signaling cascades, some of which 
we are only starting to link to HSP within neurons. Calcium/calmodulin-dependent protein 
kinase type IV (CaMKIV) has been implicated as a key sensor kinase in excitatory synaptic 
scaling that senses perturbations in firing through changes in intracellular Ca2+ concentration. 
The compensations are manifested in changes in excitatory quantal amplitude (Ibata et al., 2008; 
Goold & Nicoll, 2010). Moreover, expression of dominant-negative and constitutively-active 
forms of nuclear CaMKIV bidirectionally induced excitatory synaptic scaling and intrinsic 
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plasticity with no impact on inhibitory quantal amplitude (Joseph & Turrigiano, 2017). 
Interestingly, the addition of these exogenous CaMKIV constructs also shifted spontaneous 
firing rates suggesting CaMKIV activation acts as a negative feedback mechanism that controls 
neuronal activity (Joseph & Turrigiano, 2017). In parallel, knockdown of CaMKII function with 
shRNA or the non-selective CaM kinase inhibitor, KN-93, but not the inactive analog, KN-92, 
prevented synaptic inactivity-induced increase in GluA1 accumulation (Groth et al., 2010). 
Moreover, transfection of exogenous CaMKII but not a kinase-dead mutant, increased GluA1 
expression on dendrites (Groth et al., 2010). Taken together, these results point to two critical 
calcium-activated kinases that work in coordination to adjust properties of synaptic 
neurotransmission in a homeostatic manner. Conversely, there is also evidence of a role for the 
calcium-dependent phosphatase, calcineurin, in the regulation of synaptic scaling (Kim & Ziff, 
2014). 
Calcium-dependent signaling has a pervasive role in synaptic plasticity. Calcium 
abundance in presynaptic terminals drives several distinct forms of short-term plasticity, and its 
abundance, duration, and location of influx at synapses can determine the form of long-term 
plasticity induced (but see Navabi et al., 2013). Lastly, Ca2+ influx through VGCCs and possibly 
other sources activate downstream signaling cascades critical for homeostatic forms of plasticity 
– maintaining proper neuronal function amidst activity perturbation. Studies contributed over 
decades and from many experimental groups help paint a picture for how neurons function in the 
face of ongoing fluctuations in activity, however, there remains many understudied areas. What 
role do other sources of Ca2+ such as internal stores within the endoplasmic reticulum (Karagas 
et al., 2019) or through NMDARs play in HSP? What other Ca2+-dependent signaling cascades 
are activated during activity perturbation and which are responsible for inducing the 
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physiological compensations? How do these downstream mechanisms precisely regulate 
transcription, translation, and protein expression to alter physiology properly? Even more 
importantly, is calcium the only critical messenger or do neurons utilize other mechanisms to 
decode activity to help stabilize function within neural networks? 
 
Gene transcription and translation during homeostatic synaptic plasticity 
 It is now well established that de novo transcription and translation are essential 
regulators of enduring forms of synaptic plasticity. The long-standing thought is that persistent 
changes in neuronal function underlying learning and memory are driven by changes in gene 
expression and modifications in protein synthesis. Prior to the advanced genome sequencing 
techniques that are readily available today, the necessity of transcription and translation in 
enduring forms of LTP and LTD have been largely studied using inhibitors such as actinomycin-
D, DRB, anisomycin, cycloheximide, or emetine. Similarly, in HSP, it has been shown that the 
addition of the transcription inhibitor, actinomycin-D, in cortical neurons blocked TTX-induced 
increases in mEPSC amplitude (Ibata et al., 2008). Moreover, treatment with translation 
inhibitors, anisomycin and cycloheximide, or the transcriptional inhibitor, DRB, completely 
abolished homeostatic depression of AMPAR synaptic currents induced by optogenetic 
hyperactivation (Goold & Nicoll, 2010). This body of work, along with the emerging role of 
numerous chromatin regulators discussed below, suggests that regulation of activity-dependent 
transcription plays a key role in homeostatic synaptic scaling. 
 Technological advances in RNA-sequencing have allowed more recent experiments to 
precisely probe for alterations in gene expression during activity perturbation and homeostatic 
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plasticity. These new techniques have also enabled testing of specific epigenetic regulators and 
elucidating their roles in gene expression changes underlying homeostatic scaling. For example, 
Garay and colleagues (Garay et al., 2020), recently established a link between retinoic acid-
induced 1 (RAI1), a chromatin regulator, and the suppression of synaptic upscaling in neuronal 
networks. This work showed that RAI1 knockdown with shRNA strengthens basal 
neurotransmission, while occluding TTX-induced upscaling of mEPSC amplitudes. This 
regulation of synaptic upscaling can be explained by the fact that many TTX-responsive genes 
are RAI1 targets and were basally dysregulated in response to RAI knockdown. Intriguingly, 
RAI1 KD did not impair BIC-induced synaptic downscaling and had a much weaker impact on 
BIC responsive genes (Garay et al., 2020). A handful of other chromatin regulators, TET3 DNA 
demethylase (Yu et al., 2015), EHMT1/2 histone H3K9 methyltransferases (Benevento et al., 
2016), and L3MBTL1 methyl-histone binding factor (Mao et al., 2018) have similarly been 
shown to play a role in synaptic scaling, although all of these latter examples appear to promote, 
rather than suppress scaling. Although these subset of transcription regulators provide an initial 
framework for studying the role of epigenetic modifications in HSP, it is important to note that 
these molecules represent an infinitesimal fraction of the many chromatin regulators that have 
been discovered, many of which have genetic links to neurodevelopmental disorders (Gabriele et 
al., 2018). 
 
Reconciliation of shared mechanisms between Hebbian and homeostatic plasticity; 
metaplasticity 
 Although Hebbian forms of plasticity such as LTP and LTD are thought to promote 
neural circuit formation in development and learning and memory in the mature brain, it is 
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important to note that the rules by which these forms of plasticity are implemented are 
themselves modifiable. For example, the recent history of pre- and postsynaptic activities plays a 
critical role in the nature of LTP/LTD that is induced subsequently, a phenomenon termed 
“metaplasticity” or the plasticity of synaptic plasticity (Abraham & Bear, 1996). A clear example 
of metaplasticity was demonstrated by Huang and colleagues (Huang et al., 1992) where they 
showed a history of NMDAR activation can inhibit subsequent LTP induction suggesting that 
LTP induction parameters are continually adjusted and is highly dependent on the activity 
history of a neural circuit. The involvement of NMDAR activation history and inhibition of LTP 
induction has been validated by other experimental groups (Coan et al., 1989; Youssef et al., 
2006) and has also been shown to facilitate subsequent LTD (Christie & Abraham, 1992). With 
the rapidly increasing wealth of different synaptic plasticity mechanisms that have emerged over 
the last century, one of the biggest challenges is understanding how they work in concert to 
maintain a properly functioning central nervous system. 
 The interplay between Hebbian and homeostatic plasticity is one connection that has 
received significant focus. HSP, either through homeostatic regulation of synaptic weights or 
firing rate, has been theorized as the mechanism for constraining extreme and aberrant levels of 
neuronal activity while guiding activity-dependent circuit organization and maintaining synapse 
specific “learned experiences.” An important feature, however, is that both forms of plasticity act 
on vastly different time scales. Hebbian mechanisms are synapse specific, are implemented over 
minutes to hours (LTP/LTD), and alone, are known to promote instability in neural circuits 
(Rochester et al., 1956; Miller, 1996). By contrast, synaptic scaling requires prolonged activity 
perturbation (~24hrs) and in some cases, days in vivo (Kaneko et al., 2008; Keck et al., 2013; 
Greenhill et al., 2015). This temporal paradox (reviewed in Zenke et al., 2017) points to the 
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possibility that homeostatic plasticity mechanisms may be too slow to compensate and stabilize 
the fast positive feedback instability of Hebbian plasticity. Moreover, computational models that 
have attempted to reconcile this time disparity found that speeding the temporal kinetics of 
homeostatic scaling was required to effectively stabilize network function (Zenke et al., 2013; 
Toyoizumi et al., 2014). 
 
Is synaptic scaling subject to metaplasticity? 
 Given the disparity in temporal kinetics between Hebbian LTP/LTD and synaptic scaling, 
a mechanism thought to curtail the destabilizing forces of LTP/LTD, we were interested in 
whether the time-course of synaptic scaling was modifiable.  Inspired by the psychological 
concept of priming, originally introduced by Karl Lashley (Lashley, 1951; Bargh, 2014) as a 
history-dependent mechanism to increase the probability of a behavioral response, we 
hypothesized that circuits may implement scaling mechanisms more rapidly if they have a prior 
history of synaptic scaling.  In that way, circuits with a history of both Hebbian and homeostatic 
forms of plasticity would be better equipped to coordinate these processes to allow both 
information storage and stability.  Since HSP mechanisms are thought to continuously active 
from early development to the mature brain, we proposed the idea that neural circuits with a 
previous scaling history would be able to initiate these same compensatory changes at a much 
quicker rate relative to naïve circuits. As described in Chapter 3, we not only disproved this 
hypothesis, but also uncovered a form of homeostatic metaplasticity, where circuits with a prior 
history of scaling become refractory to homeostatic adaptations initiated by subsequent changes 
in network activity.  Moreover, our results suggest that lasting alterations in transcriptional 
regulation play a key role in homeostatic metaplasticity and underscore the importance of 
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understanding how the activity-dependent history of a circuit ultimately shapes the rules by 






Unique Roles of L-Type Calcium Channel Subtypes in Homeostatic Synaptic Scaling 
 
Abstract 
L-type voltage-gated Ca2+-channels (LTCCs) provide a pivotal link between membrane 
depolarization, calcium influx, and activity-dependent changes in gene expression. Such activity-
transcription coupling is critical for long-lasting forms of synaptic plasticity, including well-
studied forms of homeostatic plasticity such as synaptic scaling. A role of LTCCs in synaptic 
scaling has been demonstrated by using dihydropyridine antagonists such as nifedipine, 
nimodipine, or verapamil, but these agents do not distinguish between the two LTCC subtypes 
CaV1.2 and CaV1.3 expressed in brain. To investigate the unique roles of these LTCC subtypes, 
we examined synaptic upscaling in cultured hippocampal neurons derived from CaV1.2 
conditional and CaV1.3 constitutive knockout (KO) mice. We found distinct effects on 
homeostatic upscaling in each mutant, demonstrating that different LTCC subtypes play non-
redundant and unique roles. Basal synaptic properties were unaffected by CaV1.3 deletion, but 
CaV1.3 deficient neurons exhibited no synaptic upscaling in response to chronic activity 
suppression with tetrodotoxin (TTX). By contrast, CaV1.2 deletion in excitatory neurons induced 
a significant increase in mEPSC amplitude and enhanced surface expression of α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) at excitatory synapses, two 
signatures of homeostatic upscaling. Activity suppression in CaV1.2 deficient neurons produced 
no further increase in mEPSCs or synaptic AMPARs, suggesting that upscaling is occluded in 
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CaV1.2 KO neurons. Together, our results demonstrate unique roles for brain LTCC subtypes in 
homeostatic synaptic scaling and open up new opportunities to understand the activity-dependent 




Homeostatic synaptic plasticity (HSP) has received considerable attention, largely 
because of its pivotal role in buffering destabilizing levels of activity in neural circuits. Synaptic 
scaling is one of the most intensely studied forms of HSP and is characterized by adaptations that 
involve most or all synapses on a given neuron and enhance or depress synaptic function 
proportionately in response to chronic changes in neuronal firing rate (Turrigiano et a., 1998; 
O’Brien et al., 1998; Thiagarajan et al., 2005; Ibata et al., 2008; Gainey et al., 2009; Goold & 
Nicoll, 2010; Garcia-Bereguiain et al. 2013; Keck et al., 2013). In excitatory cortical or 
hippocampal neurons, chronic silencing of activity in vitro with tetrodotoxin (TTX), a voltage-
gated sodium channel blocker, leads to increased synaptic strength, or upscaling. Conversely, 
chronic elevation in activity with bicuculline, a competitive antagonist of gamma-Aminobutyric 
acid A (GABAA) receptors results in a homeostatic decrease in synaptic strength, or 
downscaling. Although widely studied in cultured neurons, synaptic scaling has been repeatedly 
observed in vivo in response to sensory deprivation (Desai et al., 2002; Goel et al., 2007; Keck et 
al., 2013; Barnes et al., 2017). Work primarily in cultured neurons has uncovered a wide range of 
molecular mechanisms underlying this form of homeostatic plasticity (Fernandes & 
Carvalho,2016), including changes in the abundance of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA)-type glutamate receptors at synapses (Turrigiano et al., 1998; 
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Sutton et al., 2006) and a clear dependence on Ca2+-dependent gene transcription (Schaukowitch 
et al., 2017). Remarkably, however, we still lack a clear understanding of the mechanism that 
couples activity-dependent Ca2+-signaling with functional homeostatic changes in synaptic 
strength.  
Calcium influx through voltage-gated calcium channels (VGCCs) plays a key role in 
regulating important activity-dependent processes such as neurotransmission, gene transcription, 
and synaptic plasticity (Greer et al., 2008; Nanou et al., 2018). VGCCs can be subdivided into 
several subfamilies based on their pharmacological and physiological properties: L-type (CaV1), 
T-type (CaV3), P/Q-type, R-type, and N-type (CaV2) (Catterall, 2000). Numerous studies have 
demonstrated the importance of VGCCs in the regulation of HSP processes. P/Q/N channels of 
the CaV2 family have been shown to gate homeostatic changes in presynaptic function at 
hippocampal synapses driven by loss of postsynaptic excitatory synaptic drive (Jakawich et al., 
2010; Henry et al., 2018). Similarly, loss-of-function mutations in the Drosophila cacophony 
(cac) gene, the pore-forming α1 subunit of CaV2 channels, prevent the homeostatic increase in 
quantal content at the neuromuscular junction (NMJ) induced by pharmacological or genetic 
impairment of postsynaptic glutamate receptor function (Frank et al., 2006; Müller & Davis, 
2012). More recently, Ca2+ influx through P/Q-type, but not N-type VGCCs has been shown to 
mediate bidirectional homeostatic regulation of neurotransmitter release and size of synaptic 
vesicle pools in hippocampal neuron cultures (Jeans et al., 2017). Collectively, these results 
suggest the importance of calcium-signaling through CaV2 channels in presynaptic HSP 
mechanisms.  
In the mammalian central nervous system (CNS), P/Q and N-type VGCCs are the 
primary presynaptic sources of Ca2+ influx (Wheeler et al., 1994; Christie et al., 1997), while L-
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type VGCCs exhibit pronounced expression in cell bodies and dendrites (Hell et al., 1993; 
Lipscombe et al., 2004) and are important for coupling changes in neural activity with regulation 
of gene expression (Murphy et al., 1991; Bading et al., 1993; Finkbeiner & Greenberg, 1998), 
among other roles (Tachibana et al., 1993; Christie et al., 1997; Norris et al., 1998; Sand et al., 
2001). LTCCs are classified into CaV1.1-4 based on the identity of the pore-forming α1 subunit, 
but only CaV1.2 and CaV1.3 are expressed significantly in brain (Hell et al., 1993; Lipscombe et 
al., 2004; Catterall, 2010). Ca2+ influx through LTCCs activates a number of downstream 
signaling cascades that impinge on gene regulation (Norris et al., 1998; Deisseroth et al., 1998; 
Dolmetsch et al., 2001; Weick et al., 2003; Wheeler et al., 2008; Wheeler et al., 2012). In 
addition, the C-terminal domains of both CaV1.2 and CaV1.3 have been shown to translocate into 
the nucleus and act as transcription factors (Gomez-Opsina et al., 2006; Lu et al., 2015). Several 
studies have demonstrated that the block of LTCC signaling with dihydropyridines such as 
nifedipine is sufficient to drive homeostatic upscaling of synaptic strength (Thiagarajan et al., 
2005; Ibata et al., 2008; Henry et al., 2012). Additionally, nifedipine treatment has also been 
shown to prevent the homeostatic downregulation of both NMDAR and AMPAR-mediated 
responses after chronic excitation in Channelrhodopsin 2 (ChR2)-expressing CA1 pyramidal 
neurons (Goold & Nicoll, 2010). These findings suggest that reduced LTCC signaling might 
contribute to homeostatic upscaling. However, inhibition of LTCC-dependent signaling with 
nifedipine has also been shown to block TTX-dependent upscaling in hippocampal neurons 
(Sokolova & Mody, 2008), suggesting a more complex role that includes both negative and 
positive regulation of HSP. 
CaV1.2 and 1.3 LTCCs exhibit differences in voltage-dependent activation, 
dihydropyridine sensitivity, and cellular localization (Hell et al., 1993; Koschak et al., 2001; Safa 
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et al., 2001; Scholze et al., 2001; Xu & Lipscombe, 2001; Lipscombe et al., 2004), raising the 
possibility that different LTCC subtypes play unique roles in homeostatic scaling. To test this 
idea, we examined how different LTCC subtypes support homeostatic synaptic scaling using 
hippocampal neurons isolated from CaV1.2 cKO and CaV1.3 KO mice, foregoing potential off-
target effects with the use of pharmacological LTCC antagonists. If CaV1.2 and CaV1.3 play 
overlapping roles in upscaling, then deletion of either subtype should have little impact on the 
ability of activity suppression to induce compensatory increases in excitatory synaptic strength. 
Contrary to this prediction, we found that CaV1.2 and CaV1.3 play non-redundant and unique 
roles in homeostatic upscaling. CaV1.3 deletion in neurons did not alter basal synaptic properties 
but prevented upscaling of miniature excitatory postsynaptic currents (mEPSCs) induced by 
chronic TTX treatment. By contrast, neuronal CaV1.2 deletion induced a significant increase in 
mEPSCs and enhanced synaptic AMPAR expression, two signatures of homeostatic upscaling, 
in the absence of TTX. Activity suppression did not further alter mEPSCs or synaptic AMPAR 
content, suggesting that CaV1.2 deletion occludes further homeostatic upscaling. Taken together, 
our findings suggest that CaV1.2 and CaV1.3 are each important for homeostatic synaptic scaling 
but play unique roles in establishing adaptive alterations in synapse function. 
 
Materials and Methods 
Animals 
All animal use followed NIH guidelines and was in compliance with the University of 
Michigan Committee on Use and Care of Animals. For the CaV1.2 study, conditional knockout 
mice with a pan-neuronal deletion of CaV1.2 were used (Temme et al., 2016; Temme et al., 
2017). For these experiments, mice heterozygous for the floxed CaV1.2 exon two allele were 
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maintained on a 129SvEv genetic background. Experimental animals were generated by crossing 
heterozygous floxed CaV1.2 mice (CaV1.2f/+ mice) with C57BL/6 transgenic mice that expressed 
Cre-recombinase under the synapsin I promoter (Cui et al., 2008). Offspring from the F1 cross 
that were heterozygous floxed and Cre positive (i.e., CaV1.2f/+, Synapsin-CreCre/+) were then 
intercrossed (non-sibling) with mice heterozygous floxed and Cre negative (i.e., CaV1.2f/+, 
Synapsin-Cre+/+) to achieve homozygous conditional knockout mice (CaV1.2f/f, Synapsin-
CreCre/+) and wild-type mice (CaV1.2+/+, Synapsin-Cre+/+) on an F2 129SvEv:C57Bl/6 hybrid 
background. For ease of reading, conditional knockout mice are referred to as CaV1.2 cKO and 
wild-type mice as WT throughout the text. For the CaV1.3 study, knockout mice with a global 
deletion of the CaV1.3 gene were used (Platzer et al., 2000; Clark et al., 2003; McKinney et al., 
2006). Mice were maintained on a C57BL/6 background by successively crossing heterozygous 
offspring with C57BL/6 WT mice. Experimental animals were generated by crossing 
heterozygous CaV1.3 mice with WT 129SvEv mice. Heterozygous offspring from the F1 cross 
were then intercrossed (non-sibling) to achieve homozygous knockout mice (CaV1.3−/−) and 
wild-type mice (CaV1.3+/+) on an F2 129Sve:C57Bl/6 hybrid background (hereafter referred to as 
CaV1.3 KO and WT). All comparisons were made between knockout mice and WT littermates 
and the experimenter was kept blind to genotype throughout the experiment. 
 
Cell Culture and Electrophysiology 
Dissociated postnatal (P0-2) rat hippocampal neuron cultures were prepared as previously 
described (Sutton et al., 2006). Hippocampal neuron cultures were derived from both male and 
female knockout mice and WT littermates. mEPSCs were recorded from a holding potential of – 
70 mV with an Axopatch 200B amplifier from neurons bathed in HEPES-buffered saline (HBS) 
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containing: 119 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM Glucose, 10 mM 
HEPES (pH 7.4) plus 1 µM TTX and 10 µM bicuculine; mEPSCs were analyzed with 
Synaptosoft MiniAnalysis software. Whole-cell pipette internal solutions contained: 100 mM 
cesium gluconate, 0.2 mM EGTA, 5 mM MgCl2, 2 mM ATP, 0.3 mM GTP, 40 mM HEPES (pH 
7.2). Statistical differences between experimental conditions were determined by ANOVA and 
post-hoc Fisher’s LSD test. Shifts in cumulative probability curves were analyzed by 
Kolmogorov–Smirnov test. 
 
Immunocytochemistry and Microscopy 
Surface GluA1 (sGluA1) was labeled and imaged as described previously (Sutton et al., 2006). 
Neurons were live labeled for GluA1 with rabbit polyclonal anti-GluA1 (0.01 mg/mL; Millipore 
#ABN241) for 15 min at 37°C and fixed with 2% paraformaldehyde/2% sucrose in PBS with 2.0 
mM MgCl2 and 2.0 mM CaCl2 (PBS-MC). Samples were blocked with 2% BSA in PBS-MC 
prior to labeling with Alexa555-conjugated goat anti-rabbit secondary antibody (Molecular 
Probes #A21429, 1:1000). Cells were then permeabilized with 0.1% Triton-X in PBS-MC 
followed by immunocytochemical labeling of PSD95 with mouse monoclonal anti-PSD95 (1 
µg/mL; Millipore #) for 60 min at RT and Alexa488-conjugated goat anti-mouse secondary 
antibody (Molecular Probes #A11029, 1:1000). All imaging was performed on an inverted 
Olympus FV1000 laser scanning confocal microscope with identical acquisition parameters for 
each treatment condition. Image analysis was performed on maximal intensity z-projected 
images. Analysis was performed with custom written analysis routines for ImageJ and Matlab. 
sGluA1 content at synapses was determined by measuring the integrated sGluA1 signal at puncta 
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co-localized with PSD95. Statistical differences were assessed by ANOVA, then by Fisher’s 
LSD post-hoc tests. 
 
Results 
Global Deletion of CaV1.3 Abolishes TTX-dependent Homeostatic Upscaling 
We examined the role of distinct LTCC subtypes in homeostatic upscaling by measuring 
compensatory changes in synaptic function in WT and CaV1.2/1.3-deficient neurons induced by 
chronic activity suppression with TTX (1 µM; 24-48hrs). To study the role of CaV1.3 LTCCs, we 
performed whole-cell voltage clamp recordings from neurons isolated from 8 CaV1.3 KO mice 
(51 neurons) or their WT littermates (7 WT mice; 30 neurons). At DIV14, we found that basal 
synaptic properties were highly similar between WT and CaV1.3-deficient neurons — mEPSC 
amplitude, frequency, and decay kinetics were all statistically indistinguishable between WT and 
CaV1.3 KO neurons (Figure 2.1A-D). As expected, chronic silencing of WT cultures with TTX-
treatment significantly increased mEPSC amplitudes (F (3 77) = 3.895, p<.05; post-hoc Fisher’s 
LSD, p<.005) (Figure 2.1B), without altering mEPSC frequency or mEPSC decay time (Figure 
2.1C, D). Interestingly, in neurons lacking CaV1.3, activity silencing with TTX did not 
significantly increase mEPSC amplitude, nor did we observe significant differences in mEPSC 
frequency or decay kinetics between TTX-treated and control CaV1.3 KO neurons (Figure 2.1C, 
D). The TTX-induced upscaling of mEPSC amplitudes in WT neurons can be seen in a 
significant (Kolmogorov–Smirnov test, p<.05) rightward shift in the cumulative probability 
curve of mEPSCs treated with TTX (Figure 2.1E). CaV1.3 KO neurons failed to demonstrate 
significant upscaling of mEPSC amplitudes (a significant rightward shift in the mEPSC 
distribution) after TTX treatment; in fact, a small leftward shift was observed indicating reduced 
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mEPSC amplitudes, though this was not statistically significant (Figure 2.1E). These results 
suggest that neurons lacking CaV1.3 channels develop with normal synaptic properties and that 
CaV1.3 channels are required for homeostatic upscaling induced by activity suppression in 
hippocampal neuron cultures. 
 
Conditional Knockout of CaV1.2 Increases Basal Synaptic Strength 
We next studied the role of CaV1.2 in regulating basal synaptic strength and TTX-
dependent synaptic upscaling. Whole-cell voltage clamp recordings were made from neurons 
isolated from 12 CaV1.2 cKO mice (73 neurons) and littermate WT mice (12 mice, 66 neurons). 
Unlike CaV1.3-deficient neurons, we observed a significant baseline increase in mEPSC 
amplitude in neurons lacking CaV1.2 (t(33) = 2.426, p<.05) (Figure 2.2A, B), but no change in 
mEPSC frequency (Figure 2.2C) or mEPSC decay time (Figure 2.2D). This increase in basal 
synaptic function was associated with a robust increase in synaptic AMPAR content, as revealed 
by surface expression of the AMPAR subunit GluA1 at PSD95-labeled excitatory synapses 
(Figure 2.2E, F).  As an increase in mEPSC amplitude and AMPAR content each accompany 
chronic activity suppression with TTX, these basal changes in CaV1.2 cKO neurons resemble 
synaptic upscaling. Indeed, WT neurons treated chronically with TTX exhibit a rightward shift in 
the mEPSC cumulative probability distribution that is superimposable with the mEPSC 
distribution from CaV1.2 cKO neurons recorded at baseline (Figure 2.3E). 
 
Conditional Knockout of CaV1.2 Occludes Homeostatic Upscaling 
Although the increased synaptic strength in CaV1.2 cKO neurons resembles a “pre-
scaled” state, these synaptic features could arise through mechanisms independent of 
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homeostatic signaling. If, on the other hand, the synaptic changes are related to normal upscaling 
driven by activity suppression, then chronic silencing of CaV1.2 cKO neurons should not further 
increase mEPSC amplitude or synaptic AMPAR content. To test these possibilities, we treated 
both WT and CaV1.2 cKO neurons with TTX for 24-48hrs and recorded mEPSCs and sGluA1 
content at PSD95-labeled excitatory synapses.  
We observed robust TTX-dependent homeostatic upscaling in WT controls reflected by a 
significant increase in mEPSC amplitude (F(3,132) = 2.920, p<.05; Fisher’s LSD, p<.05) 
(Figure 2.3B), without changes in mEPSC frequency or decay time (Figure 2.3A-D). By 
contrast, TTX was ineffective in further increasing the enhanced mEPSC amplitude in CaV1.2 
cKO neurons. Moreover, while TTX induced a clear rightward shift in the WT mEPSC 
amplitude cumulative probability distribution (Kolmogorov-Smirnov test, p<.05), it failed to 
significantly shift the distribution of mEPSCs from CaV1.2 cKO mice (Figure 2.3E).  
Numerous studies have demonstrated a direct relationship between synaptic scaling and 
the regulation of surface AMPARs at postsynaptic sites (O’Brien et al., 1998; Thiagarajan et al., 
2005; Sutton et al., 2006; Gainey et al., 2009; Garcia-Bereguiain et al., 2013; Chowdhury & 
Hell, 2018). We thus compared surface GluA1 intensity at synapses (co-localized with PSD95) 
between WT (3 mice, 80 neurons) and CaV1.2 cKO (3 mice, 79 neurons) neurons treated with 
TTX or vehicle (H2O). TTX-treatment significantly increased surface GluA1 expression at 
synapses in WT neurons but not in CaV1.2 cKO neurons (F(3,155) = 3.152, p<.05; Fisher’s LSD, 
p<.05) (Figure 2.3F, G). Consistent with previous studies (Turrigiano et al., 1998; Nanou et al., 
2018) and our mEPSC frequency data, TTX treatment did not alter synapse density (PSD95 
puncta density) in either WT or CaV1.2 cKO neurons (Figure 2.3H). Collectively, our studies 
reveal that CaV1.3 and CaV1.2 play non-overlapping roles in homeostatic synaptic scaling — 
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CaV1.3 channel function appears necessary for homeostatic upscaling even when neurons 
express CaV1.2, while loss off CaV1.2 induces an upscaling-like phenotype that occludes 
synaptic adaptations induced by activity suppression. 
 
Discussion 
L-type voltage-gated calcium channels are thought to play a role in decoding neural 
activity changes that ultimately drive compensatory synaptic adaptations underlying homeostatic 
scaling.  Direct support for the role of LTCCs has come primarily from pharmacological 
inhibition using dihydropyridines, but these drugs have potential off-target effects and cannot 
readily distinguish between roles of different LTCC subtypes.  In this study, we used a genetic 
approach to individually delete CaV1.3 and CaV1.2 to test if these LTCC subtypes play redundant 
or unique roles in homeostatic synaptic scaling. Redundant roles could be inferred if deletion of 
either CaV1.2/1.3 alone led to minimal or no alterations in synaptic scaling, implying that loss of 
a specific LTCC subtype can be mitigated by expression of the other. Instead, we found that 
deletion of either CaV1.2 or CaV1.3 had pronounced, yet distinct, effects on homeostatic 
upscaling thus demonstrating that these LTCC subtypes play unique roles in HSP. 
Previous studies point to an important role of LTCC function in negatively regulating 
homeostatic upscaling, as application of LTCC antagonists drive compensatory increases in 
synaptic function that resemble upscaling driven by activity suppression (Thiagarajan et al., 
2005; Ibata et al., 2008; Henry et al., 2012).  Consistent with this role, we find that neuronal 
CaV1.2 deletion increases basal synaptic strength and synaptic AMPAR content, and these 
synaptic changes occlude homeostatic synaptic strengthening in response to activity suppression.  
These findings support the idea that a reduction in CaV1.2 LTCC activity is a key part of the 
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signaling network that drives homeostatic upscaling, though they are not definitive. Future 
studies are needed to validate the idea that loss of ongoing CaV1.2 LTCC activity is a normal 
trigger for homeostatic upscaling during reduced neural firing rates.  For example, chemo-
genetic approaches could be used to specifically disrupt CaV1.2 LTCCs to evaluate the extent to 
which transcriptional changes and synaptic adaptations overlap with that driven by activity 
suppression.   
On the other hand, prior studies have also suggested that intact LTCC signaling is needed 
for HSP, as co-application of LTCC antagonists with TTX prevents synaptic upscaling 
(Sokolova & Mody, 2008).  Our results raise the intriguing possibility that this positive 
regulatory role for LTCCs is mediated by CaV1.3 LTCCs, since CaV1.3 deletion also disrupted 
upscaling without altering basal synaptic properties.  This result suggests that rather than 
aggregate LTCC activity being a simple cellular readout of neural activity, perhaps 
combinatorial signaling through CaV1.2 and CaV1.3 LTCCs might be important for homeostatic 
signaling during chronic changes in network activity.  It is now of interest to determine if unique 
roles for LTCC subtypes are similarly evident during homeostatic downscaling induced by 
network hyperactivation, as previous studies have demonstrated that Ca2+ influx through LTCCs 
is necessary for structural and functional adaptations driven by persistent increases in firing rates 
(Goold & Nicoll, 2010; Siddoway et al., 2013).  It is also important to determine how LTCC 
subtypes each contribute to downstream effectors that regulate transcription and/or translation to 
induce the functional changes during synaptic scaling. CaMKIV has been implicated as a 
downstream signaling protein that encodes the Ca2+ signal during activity perturbations (Goold 
& Nicoll, 2010; Joseph & Turrigiano, 2017), and CaV1.2 and CaV1.3 have been found to play 
distinct roles in pCREB signaling (Zhang et al., 2006). Our work suggests that unique roles of 
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CaV1.2 and CaV1.3 during synaptic scaling may provide a handle to better understand 
homeostatic signaling pathways that couple alterations in neural activity to gene-expression 






Figure 2.1 Global Deletion of CaV1.3 Abolishes TTX-dependent Homeostatic Upscaling (A) 
Representative whole-cell voltage clamp recordings of hippocampal cultured neurons derived 
from CaV1.3 KO mice and WT littermate controls; scalebar: 20pA, 5s (top), 20 pA, 500ms 
(bottom). (B) Mean (±SEM) mEPSC amplitudes recorded from WT and CaV1.3 KO neurons 
treated with TTX or vehicle; *p<0.05 by one-way ANOVA and Fisher’s LSD. (C) Mean 
(±SEM) mEPSC frequencies from WT and CaV1.3 KO neurons treated as indicated. (D) Mean 
(±SEM) mEPSC decay times from WT and CaV1.3 KO neurons treated as indicated. (E) 
Cumulative probability distributions of mEPSC amplitudes in WT (top) and CaV1.3 KO (bottom) 






Figure 2.2 Conditional Knockout of CaV1.2 Increases Basal Synaptic Strength and Surface 
Expression of GluA1 at synapses (A) Representative whole-cell voltage clamp recordings of 
hippocampal cultured neurons derived from CaV1.2 cKO mice and WT littermate controls; 
scalebar: 5s, 20pA. (B) Mean (±SEM) mEPSC amplitudes recorded from WT and CaV1.2 cKO 
neurons; *p<.05 by unpaired t-test. (C) Mean (±SEM) mEPSC frequencies from WT and CaV1.2 
cKO neurons treated as indicated. (D) Mean (±SEM) mEPSC decay times from WT and CaV1.2 
cKO neurons treated as indicated. (E) Representative immunocytochemistry images of WT (top) 
and CaV1.2 cKO neurons (bottom) probed with antibodies against PSD95 (green) and surface 
GluA1 (red); scalebar = 10 μm. (F) Mean (±SEM) surface GluA1 expression at PSD95-puncta 




Figure 2.3 Conditional Knockout of CaV1.2 Occludes TTX-dependent Upscaling of mEPSC 
Amplitudes and Surface GluA1 Expression (A) Representative whole-cell voltage clamp 
recordings of hippocampal cultured neurons derived from CaV1.2 cKO (bottom) mice and WT 
(top) littermate controls; scalebar: 500ms, 20pA. (B) Mean (±SEM) mEPSC amplitudes recorded 
from WT and CaV1.2 cKO neurons treated with TTX or vehicle; *p<.05 by one-way ANOVA 
and Fisher’s LSD. (C) Mean (±SEM) mEPSC frequencies from WT and CaV1.2 cKO neurons 
treated as indicated. (D) Mean (±SEM) mEPSC decay times from WT and CaV1.2 cKO neurons 
treated as indicated. (E) Cumulative probability distributions of mEPSC amplitudes in WT and 
CaV1.2 cKO neurons treated with TTX or vehicle; *p<.05 Kolmogorov-Smirnov’s test. (F) 
Representative linearized dendrites of WT (top) and CaV1.2 cKO (bottom) neurons probed with 
antibodies against PSD95 (green) and surface GluA1 (red); scalebar = 5 μm) (G) Mean (±SEM) 
surface GluA1 expression at PSD95-puncta positive synapses; *p<.05 by one-way ANOVA and 





Activity-dependent History in Hippocampal Neurons Dictate Temporal Dynamics of 
Homeostatic Synaptic Scaling 
 
Abstract 
Neural circuits utilize a host of homeostatic plasticity mechanisms, including synaptic 
scaling, to maintain stability in circuits undergoing experience-dependent remodeling necessary 
for information processing. During synaptic scaling, compensatory adaptations in synaptic 
strength are induced after chronic manipulations in neuronal firing, but our understanding of this 
process is largely limited to its initial induction. How these homeostatic synaptic adaptations 
evolve when activity renormalizes and their impact on subsequent homeostatic compensation are 
both poorly understood.  To examine these issues, we investigated whether a previous history of 
homeostatic scaling in networks of cultured hippocampal neurons altered their subsequent 
homeostatic responses to chronic activity manipulations. Unexpectedly, we found that a history 
of synaptic scaling strongly suppressed future scaling to the same, and even opposite, activity 
challenges. This history-dependent suppression was specific for future homeostatic 
compensation, as networks with a prior scaling history showed no deficits in the chemical 
induction of long-term potentiation (cLTP), a Hebbian form of synaptic plasticity. Hippocampal 
neurons with a prior scaling history exhibited normal engagement of activity-dependent 
signaling during subsequent activity challenges (as assessed by examination of the ERK/MAPK 
pathway) but demonstrated widespread alterations in activity-dependent transcriptional 
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regulation to further activity changes. We also investigated what features of synaptic 
scaling are most tightly associated with history-dependent suppression and found that the 
resetting of synaptic weights upon activity renormalization plays a key role: extending this 
resetting period or eliminating it altogether both abolished the suppressing effects of prior 
scaling history on future homeostatic scaling. Taken together, our data show that the history of 
homeostatic signaling in neural circuits plays a key role in shaping future compensatory 
adaptations to chronic changes in network activity. 
 
Introduction 
 Homeostatic forms of synaptic plasticity are thought to promote long-term stabilization 
of neural circuit function by buffering aberrant increases or decreases in network activity. The 
most intensely studied homeostatic form of plasticity is synaptic scaling, characterized by 
compensatory increases (upscaling) or decreases (downscaling) in excitatory synaptic strength 
that counters network activity suppression or hyperactivation (Turrigiano et al., 1998; O’Brien, 
1998; Lissin, 1998), respectively. Hebbian forms of plasticity, though critical for information 
storage in neural circuits, are thought to be a major source of instability for network activity 
through the positive feedback plasticity effects they promote (Keck et al., 2017; Zenke et al., 
2017). Although synaptic scaling and other forms of homeostatic plasticity have been proposed 
as a mechanism to constrain instability driven by Hebbian forms of plasticity (Rabinowitch & 
Segev, 2006; Yger and Gilson, 2015), these have been found to act on vastly different timescales 
– Hebbian plasticity on orders of seconds to minutes while synaptic scaling is induced over hours 
or days (Zenke et al., 2017). This raises the question of whether the effectiveness of synaptic 
scaling in buffering changes in neural activity is necessarily limited to prolonged periods of time, 
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or whether the activity-dependent history of synapses might regulate the timescale over which 
homeostatic adaptations are implemented. Presumably, over the lifetime of a neural circuit, 
homeostatic mechanisms would be engaged repeatedly to offset destabilization, yet how the 
history of prior synaptic scaling affects subsequent homeostatic signaling remains completely 
unknown. 
 It is well established that the activity-dependent history in neural circuits can shape the 
rules and mechanisms by which plasticity is expressed. This concept of “metaplasticity,” 
(Abraham & Bear, 1996) that synaptic plasticity is itself plastic, has been extensively studied in 
the context of Hebbian forms of plasticity (Huang et al., 1992; Cohen et al., 1999; Mellentin et 
al., 2007; Rosenberg et al., 2016), but is only beginning to be applied to homeostatic plasticity 
(Arendt et al., 2015). Given the effectiveness of synaptic scaling in buffering Hebbian-driven 
instability is theoretically enhanced by more closely aligning the temporal dynamics of the two 
(Yger & Gilson, 2015; Zenke et al., 2017), we reasoned that perhaps the dynamics of scaling 
might be accelerated in networks that have a prior history of synaptic scaling – in other words, 
that the features of homeostatic plasticity might be shaped by previous homeostatic signaling. To 
address this question, we examined how a previous round of synaptic scaling in networks of 
cultured hippocampal neurons altered homeostatic responses to a second set of activity 
challenges. Contrary to our prediction, we found that a history of synaptic scaling did not 
promote or accelerate subsequent homeostatic scaling, but rather potently suppressed it. This 
history-dependent suppression of synaptic scaling is specific, appears to be mediated largely by 
altered activity-dependent transcriptional regulation, and is closely tied to the resetting phase of 
scaling where synaptic strength returns to basal levels following a renormalization of network 
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activity. Together, our results demonstrate that homeostatic adaptations to altered network 
activity are potently regulated by the history of homeostatic signaling in neural circuits. 
 
Materials and Methods 
Animals 
All animals followed NIH guidelines and was in compliance with the University of 
Michigan Committee on Use and Care of Animals. 
 
Cell Culture 
Dissociated postnatal (P0-2) hippocampal neuron cultures were prepared from both male 
and female Sprague Dawley rat pups as previously described (Henry et al., 2018) and maintained 
until DIV14 prior to experiments. Briefly, hippocampi were dissected in cold dissociation media 
(DM in mM; 82 Na2SO4, 30 K2SO4, 5.8 MgCl2-6H2O, .252 CaCl2-2H2O, 1 HEPES, 200 
glucose, 0.001% w/v phenol red), and transferred to a 15 mL conical tube. Dissociation media 
(DM) was gently removed with enough to cover the tissue and replaced with 5mL of pre-warmed 
(37°C) cysteine-activated papain solution containing 3.2 mg l-cysteine (Sigma-Aldrich) and 
500µL papain (Sigma-Aldrich) in 10mL DM, pH~7.2. The tissue was then incubated in the 
activated papain solution for 15min at 37°C to allow for tissue digestion, inverting the tube ~2-3 
times halfway into the incubation. Papain inactivation was achieved with two washes in ice-cold 
DM containing 12.5% v/v fetal bovine serum, followed by two washes in DM alone. Dissociated 
cells were then washed twice in chilled normal growth medium [NGM; Neurobasal A 
(Invitrogen) supplemented with 2% v/v B27 (Invitrogen) and 1% v/v Glutamax (Invitrogen)], 
then titurated in 5mL NGM to obtain a single cell suspension. This single cell suspension was 
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incubated on ice for ~3-5min. The single cell suspension is transferred to a new 15mL conical 
tube and centrifuged at 67xg (0.5 x 1000 rcf) at 4°C. For plating, ~60K cells (in a volume of 
150µL) were dispensed onto poly-D-lysine-coated glass-bottom Petri dishes (Mattek) and 
maintained at 5% CO2 and 37°C. Cells were then supplied with 2mL of NGM-GC (NGM 
supplemented with 15% v/v glial conditioned media and 10% v/v cortical conditioned media) 
approximately 4hrs after plating. The next day, cells were fed by replacing 50% of the total 
volume with fresh NGM-GC and fed every 4d. By DIV14, cells were then maintained with 
NGM alone and fed on the same schedule. 
 
Electrophysiology 
mEPSCs were recorded from a holding potential of -70mV with an Axopatch 200B 
amplifier from pyramidal neurons bathed in HEPES-buffered saline (HBS) containing (in mM): 
119 NaCl, 5KCl, 2 CaCl2, 2 MgCl2, 30 Glucose, 10 HEPES (pH 7.4). Prior to recordings, 
neurons were treated with 1µM tetrodotoxin or 10µM bicuculline as indicated in experimental 
conditions. Before any pharmacological treatment, ~50% of the neuronal conditioned media 
were removed from dishes and saved at 5% CO2 and 37°C. Pharmacological agents were 
removed via 2x washes (leaving only enough media to cover the cells between washes, ~50µL) 
with fresh pre-warmed NGM and then incubated for 48hrs, unless indicated otherwise, in 50:50 
saved media and fresh NGM. 
Pharmacological induction of LTP in cultured hippocampal neurons was achieved via 
brief (5 min) exposure to a Mg2+−free HBS solution supplemented with (in mM): 0.4 Glycine 
(Fisher, Waltham, MA), 0.02 Bicuculline (Tocris), and 0.003 Strychnine (Tocris, Bristol, UK) 
Neurons were immediately washed with warm HBS after glycine stimulation and recorded from. 
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Statistical differences between experimental conditions were determined by one-way ANOVA 
and post-hoc Dunnett’s multiple comparisons test, unless indicated otherwise. Shifts in 
cumulative probability curves were analyzed by Kolmogorov-Smirnov test. 
Immunocytochemistry and Microscopy 
 Surface GluA1 (sGluA1) was labeled and imaged as previously described (Sutton et al., 
2006). Neurons were live labeled for GluA1 with rabbit polyclonal anti-GluA1 (0.01 mg/mL; 
Millipore #ABN241) for 15min at 37°C, washed with pre-warmed PBS-MC, and fixed with 2% 
paraformaldehyde/2% sucrose in PBS with 2.0 mM MgCl2 and 2.0 mM CaCl2 (PBS-MC). 
Samples were blocked with 2% BSA in PBS-MC prior to labeling with Alexa555-conjugated 
goat anti-rabbit secondary antibody (Molecular Probes #A21429, 1:1000). Cells were then 
permeabilized with 0.1% Triton-X in PBS-MC followed by immunocytochemical labeling of 
PSD95 with mouse monoclonal anti-PSD95 (1µg/mL; Millipore #MAB1596) for 60min at RT 
and Alexa4880conjugated goat anti-mouse secondary antibody (Molecular Probes #A11029, 
1:1000). All imaging was performed on an inverted Olympus FV1000 laser scanning confocal 
microscope with identical acquisition parameters for each treatment condition. Normalized 
values to the Baseline condition were used to make comparisons between repeated experiments. 
Analysis was performed with custom written analysis routines for ImageJ and Matlab. sGluA1 
content at synapses was determined by measuring the integrated sGluA1 signal at puncta co-
localized with PSD95. Synapse density was measured by the number of PSD95 puncta 
normalized to the length of the straightened dendrite. Statistical differences were assessed by 






 Samples were collected in lysis buffer containing (in mM) 100 NaCl, 10 NaPO4, 10 
Na4P2O7, 10 lysine, 5 EDTA, 5 EGTA, 50 NaF, 1 NaVO3, 1% Triton-X, 0.1% SDS, and 1 
tablet of Complete Mini protease inhibitor (Roche) per 7mL, pH 7.4. Protein concentrations of 
samples were determined using a spectrophotometer. Equal amounts of protein for each sample 
were loaded and separated on ~10-12% polyacrylamide gels, then transferred to PVDF 
membranes. Blots were blocked with Tris-buffered saline containing 0.1% Triton-X (TBST) and 
5% nonfat milk for 60min at RT or overnight at 4°C, and incubated with polyclonal anti-rabbit 
Phospho-p44/42 MAPK (pERK1/2) (1:1000; Cell Signaling #9101) antibody for 60min at RT. 
After washing with TBST, blots were incubated with HRP-conjugated anti-rabbit or anti-mouse 
secondary antibody (1:5000; Jackson Immunoresearch), followed by enhanced 
chemiluminescent detection (GE Healthcare). Phospho-p42/44 MAPK antibody was stripped and 
re-probed (https://www.novusbio.com/support/support-by-application/stripping-for-reprobing) 
with polyclonal anti-rabbit p44/42 MAPK (ERK1/2) (1:1000; Cell Signaling #9102). To confirm 
equal loading, protein concentrations of each sample were assessed using spectrometry. 
Additionally, all blots were probed with a mouse monoclonal antibody against α-tubulin (1:5000; 
Sigma-Aldrich) to confirm equal loading. Band intensity was quantified with densitometry with 
ImageJ and expressed relative to the matched control sample. Statistical differences between the 
treatment conditions were assessed by One-way ANOVA and comparisons were made to the 





Activity Alteration and BrU-seq Analysis 
 To achieve enough neurons, both cortical and hippocampal tissue were isolated as 
described. Neurons were plated onto poly-D-lysine-coated 6-well cell culture plates at a density 
of ~3 million cells/well. Cells were plated with ~1mL NGM per well and then supplemented 
with ~1mL of NGM-GC 2hrs after plating. Prior to experimental treatments, neurons were 
maintained at 5% CO2 and 37°C and fed NGM-GC every 4 days until DIV14. At the start of the 
experiment, each well contained ~3mL of media. Similarly, to our electrophysiology 
experiments, 1mL of initial conditioned media is removed and saved for the drug-washout 
period. After removal, neurons were treated with either TTX or Veh (1:1000; 1µM TTX) for 
24hrs. The initial TTX/Veh treatment was thoroughly removed via 2x washes (leaving ~500µL 
of media to cover the cells each wash) and lastly maintained with a final 50:50 saved media and 
fresh NGM solution for 48hrs before secondary treatment. On DIV17, cells were treated with 
TTX or Veh. 3.5hrs post-treatment, bromouridine (BrU, Sigma, 18670, dissolved in PBS) was 
added to cultures at 2mM final concentration and incubated at 5% CO2 and 37°C for the final 
.5hrs. Cultures were harvested in Tri-reagent BD (Sigma, T3809) and frozen immediately. RNA 
was purified using phenol-chloroform extraction and isopropanol precipitation, treated with 
DNase-I (NEB, M0303) then fragmented by high-magnesium, high temperature incubation. 
Enrichment of BrU-containing RNA and library preparation were performed as previously 
described (Paulsen et al., 2013; Paulsen et al., 2014; Garay et al., 2020). After confirming the 
quality of sequencing data by FastQC, reads were mapped to rn6 reference genome using 
Bowtie2 (Langmead & Salzberg, 2012) and annotated with Tophat 2 (Kim et al., 2013). 
Adaptors were trimmed using BBDUK (https://jgi.doe.gov/data-and-tools/bb-tools/), when 2-30 
bp on the left of the read matched the predicted adaptor (k = 30, mink = 2, minlength = 15, hdist 
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= 1). Bru-seq signals were quantified by FeatureCounts (Liao et al., 2014). Differentially 
expressed genes were identified using DESeq2 (Love et al., 2014). Gene ontology analysis of the 
top 100 (padj < 0.05) DE-genes were assessed using PANTHER (http://geneontology.org/; 
Ashburner et al., 2000; Gene Ontology Consortium, 2021). 
 
Results 
A history of synaptic scaling in hippocampal cultures prevent subsequent activity-dependent 
changes in synaptic strength 
 Chronic silencing of neuronal activity (>24hrs) initiates robust compensatory upscaling 
of excitatory synaptic function, typically revealed as an increase in the amplitude of miniature 
excitatory postsynaptic currents (mEPSCs) (Turrigiano et al., 1998; Lissin et al., 1998; O’Brien 
et al., 1998; Thiagarajan et al., 2005; Sutton et al., 2006; Jakawich et al., 2010; Garay et al., 
2020). Presumably, over the life-time of a neural circuit, synaptic up- and downscaling are 
engaged repeatedly to buffer potentially destabilizing levels of activity, raising the question of 
how a previous history of synaptic scaling affects subsequent homeostatic responses to 
alterations in network activity. Here we sought to test the resiliency of synaptic upscaling 
mechanisms focusing on whether networks of cultured hippocampal neurons exhibit changes in 
homeostatic synaptic adaptations depending on their prior scaling history. Since mEPSC 
recordings are not amenable to repeated measurements over days, we measured mEPSC changes 
a single time in four experimentally distinct groups subjected to the same 96hr experimental 
timeline where two separate 24hr exposures to TTX (1µM) or vehicle were applied with a 48hr 
washout period in between: 1) Baseline (n = 14): neurons that received only vehicle treatment; 2) 
Upscaled (n = 15): neurons treated with vehicle first, followed by TTX from 72-96hrs; 3) Reset 
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(n = 21): neurons treated with TTX from 0-24hrs, then with vehicle from 72-96hrs; and 4) 
Rescale (n = 17): neurons treated with TTX at both 0-24hrs and 72-96hrs, separated by a 48hr 
washout period (Figure 3.1A). This paradigm allowed us to compare the efficacy of upscaling in 
naïve neurons (Upscaled) relative to those with a prior history of upscaling (Rescale). As is well-
established, we found that naïve neurons (Upscaled) exhibited robust compensatory increases in 
mEPSC amplitude after 24hr TTX relative to baseline (F(3,63) = 11.65, p < 0.0001; post-hoc 
Dunnett’s multiple comparisons test, p < 0.0001) (Figure 3.1B-C). This compensatory increase 
in synaptic strength reset to basal levels upon removal of TTX for 72hrs (Baseline vs Reset: p = 
0.9969) (Figure 3.1C). Surprisingly, however, neurons with a prior history of upscaling showed 
no evidence of upscaling when challenged with TTX a second time; mEPSC amplitudes were 
nearly identical to baseline levels (Baseline vs Rescale: p = 0.9999) (Figure 3.1C). The TTX-
induced upscaling in naïve networks (Upscaled) can be seen in a significant (Kolmolgorov-
Smirnov test, p<.05) rightward shift in the cumulative probability curve with mEPSC 
amplitudes, a shift that is not evident in the Rescale group (Figure 3.1F). Consistent with 
postsynaptic mechanisms, we did not observe any significant changes in mEPSC frequency or 
decay time in any of the groups (Figure 3.1D-E). 
 We next sought to test whether these history-dependent effects would also be evidence 
with synaptic downscaling induced by chronic network hyperactivation. We used a similar 
experimental paradigm (Figure 3.2A), where two separate 24hr exposures of GABA-A receptor 
antagonist, bicuculline (Bic, 10µM), were delivered – spaced by a 48hr wash period to cultured 
networks of hippocampal neurons and recorded mEPSCs in 4 groups: 1) Baseline (n = 13): 
neurons that received only vehicle treatment; 2) Downscaled (n = 8): naïve networks receiving 
vehicle from 0-24hrs and activated with Bic at 72-96hrs; 3) Reset (n = 11): neurons treated with 
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Bic from 0-24hrs, then vehicle from 72-96hrs; and 4) Rescale (n = 11): neurons exposed to Bic 
twice, at 0-24hrs and 72-96hrs. As expected, we observed robust synaptic downscaling in naïve 
networks treated with Bic from 72-96hrs (Downscaled) reflected by a significant reduction in 
mEPSC amplitudes relative to Baseline (F(3,39) = 5.205, p = 0.0040; post-hoc Dunnett’s 
multiple comparisons test, p = 0.0494) (Figure 3.2C), as well as a significant leftward shift in 
the cumulative distribution of mEPSC amplitudes (Figure 3.2F). This compensatory depression 
in synaptic strength returned to basal levels following removal of Bic (Baseline vs Reset: p = 
0.2967) (Figure 3.2C). As we observed with synaptic upscaling, we found a marked suppression 
of synaptic downscaling in cultures with a prior downscaling history (Baseline vs Rescale: p = 
0.7285) (Figure 3.2C, F). No significant changes in mEPSC frequency or decay times were 
evident in any of the experimental groups (F(3,39) = 6.338, p = 0.5677; F(3,39) = 6.780, p = 
0.5708, respectively) (Figure 3.2D-E). Together, these results indicate a prior history of synaptic 
scaling suppresses further homeostatic scaling to later changes in network activity. 
 
Scaling-history dependent suppression of subsequent scaling events is directionally independent 
 We observe suppression of homeostatic changes in mEPSC amplitude in pre-scaled 
neuronal networks when the circuit is challenged repeatedly. We next asked how scaling history 
affects homeostatic responses to the opposite pattern of network alteration – for example, do 
previously downscaled networks exhibit altered homeostatic responses to upscaling induced by 
activity silencing or are these history effects only evident with scaling in the same direction? To 
address this question, we again exposed neurons to scaling epochs (24hrs) separated by a 48hr 
washout period and performed whole-cell mEPSC recordings in control neurons receiving 
vehicle alone (Baseline, n = 9), downscaled neurons exposed to Bic from 0-24hrs followed by 
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washout and vehicle treatment (Reset, n = 8), and previously downscaled neurons chronically 
silenced with TTX from 72-96hrs (Rescale, n = 10). We compared this Rescale group with 
neurons exposed to vehicle from 0-24hrs and TTX a single time from 72-96hrs (Naïve TTX) 
(Figure 3.3A). As shown in Figure 3B-E, downscaled mEPSCs in neurons return to basal levels 
following washout (F(2,24) = 0.1362, p = 0.8733; Baseline vs Reset: p = 0.8402), but later 
silencing with TTX for 24hrs is ineffective at upscaling mEPSCs (Baseline vs Rescale: p = 
0.9930), while naïve neurons exhibit robust upscaling to the same TTX exposure (Figure 3.3C). 
We found similar results when switching the order of up- and downscaling regiments (Figure 
3.3F): a previous history of upscaling also suppressed downscaling in response to later Bic 
challenge (F(2,18) = 0.2526, p = 0.7795) (Figure 3.3H). Collectively, these data suggest that, 
regardless of direction, a previous history of synaptic scaling suppresses subsequent homeostatic 
adaptations to chronic changes in activity. 
 
Prior scaling is required for the suppression of subsequent scaling events and this suppression 
does not crossover to Hebbian forms of synaptic plasticity 
 We next asked whether a previous history of sustained network activity per se, rather 
than a synaptic scaling history, can suppress future homeostatic responses. To address this 
question, we substituted the initial 24hr TTX exposure which induces reliable upscaling with a 
4hr TTX treatment, a sustained period of activity silencing that is insufficient to induce synaptic 
scaling (Turrigiano et al., 1998; Sutton et al., 2006) (Figure 3.4A). We included the same 
positive and negative control groups as in our previous experiments: vehicle-treated (Baseline, p 
= 7), vehicle-treated neurons exposed to TTX over the last 24hrs (Upscaled, p = 9), neurons 
previously treated with 4hrs of TTX followed by a 48hr washout period (Reset, p = 9), and 
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neurons exposed to TTX from 0-4hrs and 52-76hrs (4hr TTX-Upscaled, p = 9). As expected, we 
observed robust upscaling of mEPSC amplitudes in naïve neurons (F(3,30) = 4.468, p = 0.0104; 
Baseline vs Upscaled: p = 0.0208). Neurons with a prior 4hr TTX history also exhibited robust 
upscaling in response to the second TTX challenge (Baseline vs 4hr TTX-Upscaled: p = 0.0125) 
(Figure 3.4C), suggesting that history-dependent suppression of homeostatic scaling requires 
preconditioning with activity sufficient to induce synaptic scaling. Surprisingly, while a previous 
4hr TTX exposure did not inhibit future induction of synaptic scaling, it did lead to a significant 
decrease in mEPSC frequency in both the Reset and Rescale groups. The interpretation of this 
specific result is not obvious but reflects a more complex effect of preconditioning on synaptic 
function. 
 Are neurons with a history of synaptic scaling refractory to all forms of synaptic 
plasticity or is this suppression specific for homeostatic plasticity? To address this question, we 
examined whether neurons with a prior history of synaptic upscaling had altered induction of 
Hebbian long-term potentiation (LTP). We used a well-established glycine-based chemical LTP 
(cLTP) induction protocol (400µM glycine for 10min in a low Mg2+, HBS-based, stimulus 
solution, see materials and methods) and recorded mEPSCs in naïve (Baseline, n = 10) or 
previously upscaled neurons after resetting (Reset, n = 11), and compared synaptic efficacy to 
cultures treated with glycine (Naïve cLTP, n = 12; Pre-scaled cLTP, n = 13) (Figure 3.4F). We 
found that both naïve and previously upscaled neurons show robust increases in mEPSC 
amplitude (F(3,41) = 4.005, p = 0.0137; Baseline vs Naïve cLTP: p = 0.0472; Baseline vs Pre-
scaled cLTP: p = 0.0201), but not frequency (F(3,41) = 2.217, p = 0.1006) or decay times 
(F(3,41) = 1.793, p = 0.1637) after cLTP induction (Figure 3.4H-J). Together, this data suggest 
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that the history-dependent suppression of synaptic scaling is not due to a general inhibition of all 
forms of synaptic plasticity but is rather specific for homeostatic synaptic plasticity. 
 
Deficits in synaptic upscaling also occur in the surface expression of GluA1 
 What mechanism underlies history-dependent suppression of synaptic scaling? As an 
initial inroad to this question, we considered that suppression could be levied at 3 general 
mechanistic levels: 1) At trafficking of AMPARs to synapses, as bi-directional changes in 
synaptic AMPAR abundance are a hallmark of both synaptic up- and downscaling (O’Brien et 
al., 1998; Sutton et al., 2006; Jakawich et al., 2010; Groth et al., 2011); 2) At the activity-
dependent signaling that engages downstream mechanisms necessary for synaptic scaling; and 3) 
At activity-dependent regulation of gene expression, as scaling is known to be critically 
dependent on new transcription (Ibata et al., 2008; Goold & Nicoll, 2010) and chromatin 
regulation (Yu et al., 2015; Benevento et al., 2016; Mao et al., 2018; Garay et al., 2020). 
AMPARs accumulate a synaptic sites during synaptic upscaling, so we asked whether 
suppression of scaling is associated with altered synaptic AMPAR expression or whether 
AMPARs traffic normally to synaptic sites but other mechanisms (e.g., post-translational 
modifications of receptors) account for the inhibition. We measured the surface levels of the 
AMPAR subunit GluA1 (sGluA1) at excitatory synapses by live-labeling with an anti-GluA1 
antibody specific to an extracellular epitope, then fixing, permeabilizing and labeling for the 
synaptic marker, PSD95. Comparisons were made between the same four experimental groups 
Baseline, Upscaled, Reset, and Rescale (n = 90 neurons/group) (Figure 3.5A). Consistent with 
previous observations, we found a significant increase in sGluA1 at PSD95-labeled synapses in 
neurons silenced with 1µM TTX for 24hrs (Upscaled), and sGluA1 expression largely recovered 
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to basal levels following the 48hr washout period (Reset). Unlike neurons exposed to TTX a 
single time, those with a history of prior upscaling showed no increase in sGluA1 relative to 
controls (Figure 3.5B-D). These changes in sGluA1 were not associated with addition or 
removal of synaptic sites, as synaptic density (PSD95 puncta/µm) was similar across groups 
(F(3,356) = 0.4646, p = 0.7072) (Figure 3.5E). These results indicate that the history-dependent 
suppression of synaptic scaling is reflected in synaptic AMPAR abundance, suggesting that the 
suppression is mediated at some point upstream of AMPAR trafficking to synaptic sites. 
 
Activity-dependent signaling is unaltered by a prior history of synaptic scaling 
 Might the history-dependent suppression of homeostatic scaling be due to altered 
encoding of chronic activity changes? This is a difficult question to fully address as the precise 
molecular mechanisms that encode chronic changes in activity remain poorly understood. 
However, considerable insight can be gained by asking whether activity-dependent signaling is 
regulated as a consequence of previous scaling experience. One of the most strongly activity-
regulated pathways is the extracellular signal-regulated/mitogen-activated protein kinase 
(ERK/MAPK) signaling pathway, which is known to play a key role in linking neural activity 
with transcriptional regulation, among other critical neural processes (Treisman, 1996; Blüthgen 
et al., 2017). We addressed the potential regulation of altered activity signaling by measuring 
levels of phosphorylated ERK1/2 during the initial 1, 2, and 4hrs of activity manipulation in 
naïve and pre-scaled hippocampal cultures (Figure 3.6A, E). In naïve hippocampal neurons, 
activity silencing with TTX significantly reduced ERK1/2 phosphorylation without changing 
overall ERK1/2 levels or levels of tubulin (loading control), while network hyperactivation with 
Bic significantly enhanced ERK1/2 phosphorylation (Figure 3.6C, D, G, H). These patterns 
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were virtually identical in neurons with a previous history of upscaling (Figure 3.6C, D) or 
downscaling (Figure 3.6G, H) at all three timepoints examined. These data suggest that activity-
dependent signaling is largely intact following a history of synaptic scaling implying that the 
history-dependent suppression is levied at a point downstream from initial activity decoding, 
perhaps at the level of transcriptional control. 
Synaptic upscaling induces a persistent transcriptional program 
 As transcription plays a critical role in synaptic scaling, we next asked whether history-
dependent suppression of homeostatic scaling might relate to altered activity-dependent 
regulation of gene expression. To examine transcriptional dynamics directly, we employed 
bromouridine RNA sequencing (BrU-seq) (Paulsen et al., 2013; Paulsen et al., 2014) to monitor 
newly generated transcripts over the first 4hrs of activity silencing. This genome-wide nascent 
transcript profiling technique provides an unbiased account of newly transcribed genes during 
TTX silencing of neurons. We prepared primary hippocampal and cortical neuron co-cultures 
from brain tissue isolated from P1-P2 rats and allowed them to mature for 14 days in vitro (DIV). 
We adopted the same paradigm we have used in functional studies, where neurons are treated 
with either vehicle or TTX from 0-24hrs, followed by a 48hr washout period, then either vehicle 
or TTX again for 4hrs. During the last 30mins of this second TTX treatment, we added BrU to 
the culture medium to label newly synthesized transcripts which are then isolated using magnetic 
beads coated with anti-BrU antibody and processed for next-generation sequencing (Figure 
3.7A). 
 Our BrU-seq dataset revealed high levels of intronic reads, confirming that the detected 
transcripts were recently generated and had yet to be spliced into mature RNA (Figure 3.7B). 
Differential statistical analysis (DESeq2) of gene transcripts in response to TTX silencing of 
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naïve neurons revealed an abundance of down- (916, padj < 0.05) and up-regulated genes (202, 
padj < 0.05). Comparing transcriptional responses to 4hr TTX with or without a prior scaling 
history revealed that previous scaling dampened the overall transcriptional response to activity 
silencing, as perhaps most easily appreciated in the volcano plots shown in Figure 3.7C. The 
number of TTX response genes that surpass the significance threshold is greatly reduced in pre-
scaled neurons (Downregulated: 299, padj < 0.05; Upregulated: 57, padj < 0.05) relative to naïve 
neurons. Moreover, the degree TTX-induced regulation of critical genes in synaptic plasticity 
such as brain-derived neurotrophic factor (Bdnf), neuronal pentraxin (Nptx1), and histone 
deacetylase 9 (Hdac9), are severely dampened in pre-scaled neurons (Figure 3.7C). This data 
suggests that a history of chronic activity silencing within neurons has long-lasting effects on 
future TTX-dependent gene transcription. 
 Although TTX-regulation of gene transcription is altered in pre-scaled neurons, we do 
not know at what stage these deficits start to arise – during the initial TTX challenge (Naïve 
TTX), the reset period where TTX is removed (Reset), or during the secondary TTX challenge 
(Pre-scaled TTX). As an initial probe into this issue, we looked at the FPKM (fragments per 
kilobase of transcript per million mapped reads) of widely known activity-dependent IEGs 
(immediate early genes) across our 4 experimental conditions (Figure 3.7D). Relative to 
Baseline, silencing of activity upon initial TTX treatment (Naïve TTX) results in a characteristic 
drop in FPKM in all 6 IEGs (Junb, Homer1, Egr1, Bdnf, Arc, and Fos). Unexpectedly, we found 
that these genes did not fully recover after removal of TTX in the Reset group, despite the full 
recovery of synaptic compensation (Figure 3.1). These genes were responsive to a second TTX 
treatment (Pre-scaled TTX), though this response is noticeably diminished. This incomplete 
recovery was an effect expressed by a number of genes though a number of others recovered 
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completely and responded nearly identically to a TTX challenge regardless of their activity-
dependent history (Figure 3.7G). To analyze these trends further, we categorized gene responses 
by finding the overlap of pairwise differentially regulated genes (DESeq2; p < 0.05) with genes 
that were significantly different between Baseline, Naïve TTX, Reset, and Pre-scaled TTX (Chi-
square test). From this analysis, 4 distinct groups emerged: resets and rescales, resets without 
rescale, no reset but rescales, and no reset or rescale (Figure 3.7G; Figure 3.9B). Gene ontology 
analysis (Ashburner et al., 2000; The Gene Ontology Consortium, 2021) of the top differentially 
regulated genes (padj < 0.05) between Baseline and Reset groups revealed regulation of activity-
dependent molecules including genes involved in the activity of voltage-gated cation channels, 
growth factors, and protein serine phosphatases. As expected, DE-genes were localized to 
neuronal cellular components with some of the highest hits being neuron projection, 
glutamatergic synapse, pre- and postsynapse (GO:0043005; GO:0098978; GO:0098793; 
GO:0098794) (Figure 3.9A). 
 
The reset phase plays a unique refractory role in the regulation of synaptic scaling 
 The heterogeneity in transcriptional response behavior identified in our BrU-seq dataset 
suggests that prior scaling impacts activity-dependent transcription at multiple levels. Moreover, 
the ongoing transcriptional impact following TTX washout suggest a potential role for the 
resetting phase in history-dependent suppression of scaling. To examine this possibility, we 
undertook two experiments where we specifically manipulated the features of the resetting phase 
to ask whether this impacted history-dependent suppression of synaptic scaling. First, we looked 
at extending the drug-free period from 48hrs to 96hrs (Figure 3.8A). Interestingly, the extension 
of the Reset phase completely rescued synaptic upscaling of mEPSC amplitudes in pre-scaled 
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hippocampal neurons (F(3,37) = 15.69, p < 0.0001); Baseline vs Rescale: p = 0.0014) (Figure 
3.8B). These data suggest that neurons are refractory to future homeostatic scaling during the 
reset phase and that this inhibition is time-limited. These results are consistent with a role for the 
reset phase in suppressing homeostatic scaling, but they do not rule out the possibility that the 
initial scaling event imposes a time-limited suppression of future scaling that just happens to 
coincide with the reset phase in our experiments. If the reset phase is truly deterministic, then 
neurons should show no suppression of scaling if resetting is eliminated altogether. To test this 
possibility, we examined whether neurons could upscale directly from a downscaled state. We 
treated neurons with Bic for 24hrs to induce downscaling, then immediately exposed them to 
TTX to suppress firing (Figure 3.8E) and monitored mEPSCs 48hrs later. Under these 
conditions, we observed no history-dependent suppression of upscaling – TTX treated neurons 
exhibited a significant increase in mEPSC amplitudes (F(2,20) = 17.09, p < 0.0001; Baseline vs 
Pre-scaled TTX (48hrs): p = 0.0138) with no detectable changes in mEPSC frequency or decay 
time. Collectively, this data indicates there exists a unique reset phase and that it plays a critical 
refractory role in the regulation of synaptic scaling. 
 
Discussion 
 Homeostatic forms of plasticity have been intensely studied due to their putative role in 
conferring long-term stability on network activity in neural circuits. A key question that has not 
been addressed is how such homeostatic regulation might be shaped by the history of activity 
within the circuit. We have examined this issue in networks of cultured hippocampal neurons 
and document several novel features of homeostatic synaptic scaling. First, our results 
demonstrate that functional homeostatic adaptations induced by synaptic scaling “reset” during 
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renormalization of network activity levels (Figure 3.1-3.3). While this finding is clearly 
predicted by current thinking in the field, it has surprisingly never before been empirically 
demonstrated. In an early study of synaptic protein changes during scaling, Ehlers found that 
changes in synaptic protein expression that accompany up- and downscaling do reverse to basal 
levels 48hrs after activity normalization (Ehlers, 2003), which is consistent with the changes in 
synapse function we report here. Second, we demonstrated that a prior history of synaptic scaling 
exerts profound effects on future homeostatic changes in response to the same activity 
perturbations. Hence, a history of upscaling prevented later upscaling, when induced 48hrs 
following renormalization of activity. Similarly, prior induction of Bic-induced downscaling 
suppressed future downscaling in response to the same Bic exposures. This history-dependent 
suppression of synaptic scaling was also evident when the activity changes from the initial event 
to the second event were opposite – that is, prior upscaling also suppressed future downscaling 
and vice versa. These history effects do not reflect a general dampening of synaptic plasticity, 
since a previous history of scaling did not alter the induction of cLTP at these synapses. 
Collectively, these results implicate a key role for synaptic scaling history of a network to shape 
future homeostatic adaptations to alterations in neuronal activity. 
 What is the mechanism by which initial scaling events suppress future scaling? We 
explored the underlying molecular mechanism at 3 general mechanistic levels. First, we 
demonstrate that neurons with a history of prior upscaling showed no increase in sGluA1 after 
24hrs of activity silencing, a well-established homeostatic response (Sutton et al., 2006; 
Jakawich et al., 2010; Groth et al., 2011) observed in neurons exposed to TTX a single time 
(Figure 3.5). This deficit in TTX-dependent AMPAR accumulation cannot be explained by a 
loss of synapses as synaptic density, determined by PSD95 puncta density, was similar across all 
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experimental groups (Figure 3.5E) suggesting that the suppression is mediated upstream of 
AMPAR trafficking at synapses. It is noteworthy that post-translational modifications of 
AMPAR play a critical role in synaptic scaling (Goel et al., 2011) and that future experiments are 
needed to validate whether or not altered post-translational regulation of AMPARs contributes to 
the suppression seen in our functional studies. 
 Second, we examined the possibility that activity-dependent signaling might be altered as 
a consequence of the initial scaling event, and in that way, the mechanisms that decode chronic 
activity changes would be impaired. To address this question, we analyzed activity-dependent 
ERK1/2 phosphorylation (TTX silencing and Bic hyperactivation) in naïve neurons and neurons 
with a prior upscaling history since ERK/MAPK signaling is one of the most tightly linked to 
activity modulation. Our results clearly demonstrate that activity-dependent ERK1/2 signaling is 
largely intact following scaling, as we observed characteristic decreases and increases in 
phosphorylated ERK1/2 in hippocampal neurons after TTX and Bic treatments, respectively, 
without changes in overall ERK1/2 or tubulin protein levels regardless of activity-history 
(Figure 3.6). This result implicates that ERK-dependent encoding of neuronal activity remains 
unaltered, however, there exists an extensive list of postsynaptic scaffolding proteins, 
intracellular signaling pathways, transcriptional and translational regulators, cell-adhesion 
molecules, and soluble released factors that have been found to be critical during homeostatic 
synaptic plasticity (reviewed in Fernandez & Carvalho, 2016) and could contribute to the 
suppression of scaling. 
 As new transcription has been shown to play a key role in synaptic scaling (Ibata et al., 
2008; Goold & Nicoll, 2010), we asked whether transcriptional dynamics are altered by a scaling 
history in neurons. Using a nascent mRNA sequencing approach (BrU-seq), we monitored newly 
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generated transcripts over 4hrs of activity silencing. Comparisons between transcriptional 
responses in neurons with or without a prior upscaling history revealed prior scaling severely 
dampened overall transcription of TTX-response genes (Figure 3.7B). In stark contrast to the 
resetting of functional changes we observed, many activity-dependent IEGs did not fully recover 
after renormalization of activity (Figure 3.7D). Although these genes were responsive to a 
second TTX treatment, the degree of expression was often noticeably diminished (Figure 3.7D). 
Collectively, our results suggest that history-dependent suppression of synaptic scaling 
associated with persistent changes in the activity-dependent transcriptional program of neurons. 
After further analysis of transcriptional trends, we found that gene responses fell into four 
distinct patterns: resets and rescales, resets without rescale, no reset but rescales, and no reset or 
rescale (Figure 3.7F, G, 3.9B). The emergence of these groups suggest that synaptic scaling 
does not alter the transcription of all genes equally; the recovery after initial upscaling and 
response to a secondary TTX treatment vary depending on the gene. Which gene products are 
responsible for the functional changes during scaling and which underlie the refractory 
suppression of subsequent scaling events? Our gene-ontology analysis of the top significantly 
TTX-regulated genes may provide qualitative insight (Figure 3.9A) and future experiments will 
be needed to elucidate the potential mechanisms involved. An important limitation of our BrU-
seq approach is the lack of cell type specificity. The present study does not distinguish 
transcriptional effects between excitatory or inhibitory neurons or neurons vs astrocytes. Future 
studies should examine cell-type specific transcriptional profiles using approaches such as 
INTACT or single-cell transcriptomics to address this issue. Nevertheless, our study provides 
evidence of enduring changes in transcriptional regulation that significantly outlast the initial 
scaling event and likely contribute to altered homeostatic regulation in the future. 
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 In summary, our results introduce another level of complexity when considering how 
homeostatic signaling regulates the properties of neural circuits. We show that synaptic scaling is 
not iteratively induced in a stereotyped manner, but rather, can be profoundly influenced by the 
activity-dependent history of the network. Surprisingly, this effect of activity history seems to 
require the resetting phase of synaptic scaling where scaled synaptic weights revert to basal 
levels when network activity renormalizes. Extending the resetting phase from 48 to 96hrs 
eliminated history-dependent suppression of scaling, revealing that the refractory period where 
future scaling events are suppressed is time-limited. More telling, eliminating the resetting phase 
altogether, by moving network activity directly from a hyperactive state to a suppressed state, 
also abolished history-dependent scaling. It is now of interest to determine what cellular and 
molecular mechanisms that accompany the resetting phase are key to both renormalizing 
synaptic weights and conferring suppression of future scaling. These findings illuminate distinct 
temporally-dependent molecular mechanisms that work in concert to determine homeostatic 






Figure 3.1 TTX-induced synaptic upscaling of mEPSC amplitudes is suppressed in 
hippocampal networks with a prior upscaling history (A) Experimental timeline representing 
the Rescale experimental group where hippocampal neurons are chronically silenced with TTX 
for 24hrs twice, given a 48hr drug-free period (dashed lines represent theoretical and untested 
changes in mEPSC amplitude). (B) Representative whole-cell voltage clamp recordings of 
hippocampal cultured neurons treated with only Veh (Baseline), Veh first and TTX second 
(Upscaled), TTX first and Veh second (Reset), TTX for both trials (Rescale); compressed (left; 
scalebar: 5pA, 1.25s) and expanded (right; scalebar: 10pA, 125ms). (C) mEPSC amplitude mean 
± SEM, (D) mEPSC frequency, and (E) mEPSC decay time of the four experimental groups: 
Baseline, Upscaled, Reset, and Rescale. (F) Cumulative probability distributions of mEPSC 
amplitudes in Baseline, Upscaled, Reset, and Rescale experimental groups. All graphs represent 
mean ± SEM. For (C-E), one-way ANOVA, followed by post hoc Dunnett’s multiple-
comparisons test relative to Baseline were performed; *p < 0.05, **p < 0.01, ***p < 0.001, 




Figure 3.2 BIC-induced synaptic downscaling of mEPSC amplitudes is suppressed in 
hippocampal networks with a prior downscaling history (A) Experimental timeline 
representing the Rescale experimental group where activity levels in hippocampal neurons are 
chronically elevated with BIC for 24hrs twice, given a 48hr drug-free period (dashed lines 
represent theoretical and untested changes in mEPSC amplitude). (B) Representative whole-cell 
voltage clamp recordings of hippocampal cultured neurons treated with only Veh (Baseline), 
Veh first and BIC second (Downscaled), BIC first and Veh second (Reset), BIC for both trials 
(Rescale); compressed (left; scalebar: 5pA, 1.25s) and expanded (right; scalebar: 10pA, 125ms). 
(C) mEPSC amplitude mean ± SEM, (D) mEPSC frequency, and (E) mEPSC decay time of the 
four experimental groups: Baseline, Downscaled, Reset, and Rescale. (F) Cumulative probability 
distributions of mEPSC amplitudes in Baseline, Downscaled, Reset, and Rescale experimental 
groups. All graphs represent mean ± SEM. For (C-E), one-way ANOVA, followed by post hoc 
Dunnett’s multiple-comparisons test relative to Baseline were performed; *p < 0.05, **p < 0.01, 





Figure 3.3 The suppression of synaptic scaling in previously scaled hippocampal networks 
is bidirectionally independent (A) Experimental timeline representing the Rescale experimental 
group where hippocampal neurons are chronically activated with BIC for 24hrs, reset for 48hrs, 
and then chronically silenced with TTX for 24hrs. (B) Representative mEPSC traces of Baseline, 
Reset, and Rescale (scalebar: 10pA, 125ms). (C) mEPSC amplitude (D) mEPSC frequency (E) 
mEPSC decay time (F) Experimental timeline representing the Rescale group where neurons are 
first silenced with TTX, reset with a drug-free period of 48hrs, and then chronically activated 
with BIC. (G) Representative mEPSC traces for Baseline, Reset, and Rescale (scalebar: 10pA, 
125ms). (H) mEPSC amplitude (I) mEPSC frequency (J) mEPSC decay time. All graphs 
represent mean ± SEM. For (C-E, H-J), one-way ANOVA, followed by post hoc Dunnett’s 
multiple-comparisons test relative to Baseline were performed; *p < 0.05, **p < 0.01, ***p < 









Figure 3.4 Prior scaling is required for the suppression of subsequent scaling events and 
this suppression does not crossover to Hebbian forms of synaptic plasticity (A) Experimental 
timeline showing the rescaling of mEPSCs in hippocampal neurons previously silenced with 4hrs 
of TTX. (B) Representative mEPSC traces for hippocampal cultured neurons treated with only 
Veh (Baseline), Veh first and TTX second (Upscaled), TTX for 4hrs first and Veh second 
(Reset), TTX for 4hrs first and TTX for 24hrs second (4hr TTX-Upscaled) (scalebar: 10pA, 
125ms). (C) mEPSC amplitude (D) mEPSC frequency (E) mEPSC decay time (F) Experimental 
timeline of the induction of cLTP in hippocampal neurons previously upscaled with 24hrs of 
TTX. (G) Representative whole-cell voltage clamp recordings of neurons treated with only Veh 
(Baseline), TTX first and Veh second (Reset), Veh first and glycine-stimulus second (Naïve 
cLTP), TTX first and glycine-stimulus second (Pre-scaled cLTP). (H) mEPSC amplitude (I) 
mEPSC frequency (J) mEPSC decay time. All graphs represent mean ± SEM. For (C-E, H-J), 
one-way ANOVA, followed by post hoc Dunnett’s multiple-comparisons test relative to Baseline 




Figure 3.5 A scaling history prevents subsequent upscaling of surface AMPAR expression 
at synapses (A) Experimental paradigm representing the Rescale group. (B) Full frame 
representative images of hippocampal neurons fixed after only Veh treatment (Baseline), Veh 
first and TTX second (Upscaled), TTX silencing for both trials (Rescale), immunostained for 
antibodies against the surface epitope of GluA1 (red) and synaptic marker, PSD95 (green) 
(scalebar: 20µm). (C) Representative images of straightened dendrites immunostained with 
sGluA1 antibody (red) colocalized with PSD95 puncta (green); colocalization represented in 
yellow puncta within the Merge column (scalebar: 5µm). (D) Bar graphs of the mean ±SEM 
sGluA1 intensity at PSD95 puncta normalized to % baseline. (E) Mean ±SEM number of PSD95 
puncta per µm of dendrite. (D-E) one-way ANOVA, followed by post hoc Dunnett’s multiple-
comparisons test relative to Baseline were performed; *p < 0.05, **p < 0.01, ***p < 0.001, 




Figure 3.6 Activation of the ERK/MAPK signaling cascade via ERK1/2 phosphorylation 
remains intact in previously up- and downscaled hippocampal neurons (A, C) Experimental 
timeline representing the Rescale group; neurons were collected 1hr, 2hr, and 4hr post second 
Veh/TTX/BIC treatment. (B, D) Representative immunoblots of phosphorylated ERK1/2, total 
ERK1/2, and tubulin proteins collected from hippocampal neurons only treated with Veh 
(Baseline), Veh first and TTX/Bic second (Naïve TTX/Bic), TTX/Bic first and Veh second 
(Reset), and TTX/Bic for both trials (Pre-scaled TTX/Bic). (E) Bar graphs represent the mean ± 
SEM of pERK1 normalized to percent change from Baseline at 1hr. (F) Bar graphs represent the 
mean ± SEM of pERK2 normalized to percent change from Baseline at 1hr. One-way ANOVA 
and post-hoc LSD Fisher’s test were used to compare pERK1/2 protein level differences between 





Figure 3.7 A history in synaptic upscaling in hippocampal neurons has a lasting role in 
transcription regulation (A) Experimental procedure using BrU-seq as a tool for analysis of 
nascent transcription. (B) Genome browser views of Homer1 isoform tracks with mapped reads 
of Baseline and Naïve TTX groups (bottom). Intronic reads are characteristic of nascent RNA. 
(C) Differential gene expression analysis (DESeq2) reveals widespread transcriptional changes 
in response to TTX in naïve hippocampal cultured neurons. The number and degree of 
differential regulated in response to TTX is dampened in hippocampal neurons with a prior TTX-
induced upscaling history. (D) Graphs displaying fragments per kilobase of transcript per million 
mapped reads (FPKM) values of example activity dependent IEGs for the indicated conditions. 
(E) Heatmap of all significantly altered genes in response to TTX, padj < .05. (F) Schematic 






Figure 3.8 The reset phase plays a unique refractory role in the regulation of synaptic 
scaling. (A) Experimental timeline of the Rescale experimental group where the Reset drug-free 
phase was extended to 96hrs. (B) mEPSC amplitude (C) mEPSC frequency (D) mEPSC decay 
time represented as mean ± SEM of the indicated conditions. (E) Experimental timeline where 
hippocampal cultured neurons are downscaled with 24hr BIC treatment and immediately 
silenced with TTX for 48hrs. (F) mEPSC amplitude (G) mEPSC frequency (H) mEPSC decay 
time represented as mean ± SEM of the indicated conditions. (B-D, F-H) one-way ANOVA, 
followed by post hoc Dunnett’s multiple-comparisons test relative to Baseline were performed; 














Figure 3.9 Gene Ontology and FPKM Table (A) Gene Ontology Analysis of top differentially 
regulated genes comparing Baseline and Reset groups. (B) Table of FPKM reads for typified 
significantly regulated genes identified by the overlap of DESeq2 and Chi-square analyses.
Type I Baseline Naïve TTX Reset Rescale Type III Baseline Naïve TTX Reset Rescale
Arap2 0.7700 0.3714 0.7473 0.3733 Atp2b1 5.8847 3.0330 4.4232 2.9069
Atp10a 0.1881 0.0459 0.1864 0.0517 Ccser1 1.1187 0.5132 0.7968 0.4756
Ccdc64 2.1879 1.4901 2.0695 1.5016 Cntnap4 1.6866 0.5982 0.8700 0.6106
Col23a1 0.1026 0.1590 0.1018 0.1764 Dlg2 2.4437 1.3047 1.7023 1.2008
Gpd2 1.2884 0.9965 1.2305 0.9149 Dlgap2 2.8529 1.6554 2.0992 1.5252
Gpr63 1.3252 0.6692 1.3297 0.6241 Fgf9 1.7336 0.4924 0.8308 0.4005
Htr2c 0.3606 0.1738 0.3285 0.1677 Fosl2 4.1349 0.9579 1.7874 0.9233
Kcnt2 0.9607 0.4376 0.9583 0.4561 Gabrb2 1.6209 0.8071 1.1846 0.8070
Kitlg 0.6540 0.2225 0.6811 0.2462 Gria3 1.6144 0.7336 1.2237 0.7819
Map3k5 0.5107 0.3507 0.5242 0.3741 Grm7 2.0505 0.9369 1.5261 0.9411
Mpped1 2.3472 1.3320 2.2990 1.5312 Hcn1 1.4390 0.5917 1.0469 0.6109
Neurod6 9.2229 4.7765 8.8900 4.6394 Hdac5 4.7568 2.0258 3.1805 1.8474
Nudt 1.0969 1.1325 0.7626 1.3012 Hdac9 1.7272 0.4130 1.0813 0.4960
Prkaa2 1.6861 1.0987 1.5937 1.1391 Hivep2 4.2673 2.2259 3.3057 2.3136
Rhobtb1 0.4431 0.2062 0.4656 0.2551 Htr7 0.4729 0.1484 0.2778 0.1324
Sdk2 0.9902 1.5448 1.0426 1.4535 Kcnb2 1.9895 1.2098 1.4441 0.9977
Sh3gl3 1.4127 2.1997 1.4804 2.0374 Kcnma1 2.7545 1.6199 2.1585 1.6075
Smpdl3b 0.3825 0.8414 0.4851 0.9745 Nav3 2.8098 1.3166 2.0754 1.2263
Sorl1 1.2358 0.5739 1.3217 0.5186 Nr4a1 22.6568 1.4120 5.2923 1.6190
Srgap3 2.8854 3.9629 3.0421 3.9259 Nr4a3 4.6064 0.5100 2.0655 0.6189
Tmem178a 2.5596 1.6946 2.5321 1.6879 Ppfia2 3.0756 1.6192 2.2141 1.5192
Tspan15 0.3660 0.6681 0.3942 0.7641 R3hdm2 4.5161 2.4332 3.5656 2.3784
Rapgef5 3.1517 1.3547 2.3354 1.4144
Type II Reln 1.4654 0.5709 0.9259 0.4963
Scd2 45.3346 55.6647 43.0188 43.0680 Rheb 4.8807 2.3671 3.3062 2.4729
Sema3a 0.5165 0.1506 0.3175 0.1700
Type IV Baseline Naïve TTX Reset Rescale Trhde 0.6602 0.2618 0.3514 0.2256
Akap6 3.0678 2.4519 2.3581 2.4114 Zbtb16 2.1245 1.2351 1.6498 1.1835
Fndc3a 1.7690 1.1767 1.1940 1.0970
Gbe1 0.2958 0.1522 0.1726 0.1650
Nrg2 1.8194 1.4780 1.3584 1.3056
Ntn4 0.4619 0.2157 0.2464 0.2372
P4ha2 1.0303 0.5940 0.5024 0.4776
Ranbp2 5.7824 3.9609 4.1933 4.0098
Smarca5 4.9968 3.5451 3.7113 3.8673






This dissertation examined two unique aspects of homeostatic synaptic scaling in 
networks of hippocampal neurons – the role of specific LTCC subtypes in the induction of 
synaptic upscaling and how synaptic up- and down-scaling are influenced by the history of 
homeostatic signaling in the network. The results suggest that homeostatic synaptic scaling is a 
mechanistically complex form of plasticity that depends on Ca2+-signaling through LTCCs and 
can be dissected into multiple distinct phases, an area that remains highly understudied in the 
field. Our results suggest that LTCC subtypes play distinct and non-redundant roles during the 
induction of synaptic upscaling. Moreover, our work demonstrates a complex interplay between 
homeostatic signaling and the history of activity in the network, revealing a form of homeostatic 
metaplasticity, where prior synaptic scaling suppresses future homeostatic adaptations in 
response to similar activity challenges. Further investigation into this complexity will help 
elucidate how homeostatic mechanisms confer stability and proper function in the face of on-
going activity fluctuations within neural circuits. 
 
Roles of unique LTCC subtypes in homeostatic synaptic scaling? 
Two major LTCC subtypes are expressed in the brain, CaV1.2 and CaV1.3, and it has 
remained unknown how each contributes to homeostatic forms of synaptic plasticity. Our results 
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indicate that CaV1.2 and CaV1.3 play unique roles in the regulation of both basal 
neurotransmission and homeostatic scaling. Removal of CaV1.2, but not CaV1.3, enhances basal 
synaptic strength (Figure 2.1B, 2.3B). This increase, resembling synaptic upscaling, is consistent 
with studies that show that pharmacological LTCC blockade of dihydropyridines is sufficient to 
drive homeostatic upscaling of synaptic strength (Thiagarajan et al., 2005; Henry et al., 2012). 
Further evidence that CaV1.2 removal enhances synaptic strength through a scaling-like 
mechanism comes from the fact that it drives multiplicative changes in the mEPSC amplitude 
distribution and occludes further enhancement by TTX-induced activity silencing. One the other 
hand, removal of LTCC-dependent signaling with nifedipine has been shown to interfere with 
synaptic upscaling (Sokolova & Mody, 2008), which resembles the synaptic phenotype 
accompanying CaV1.3 removal. While having no impact on basal transmission on its own, 
genetic deletion of CaV1.3 prevents synaptic upscaling induced by chronic TTX treatment 
(Figure 2.1B). Taken together, these findings suggest that LTCCs play a complex role in 
synaptic scaling that includes both positive and negative regulation of homeostatic signaling. 
 How does removal of LTCCs result in two antagonizing regulatory roles in synaptic 
strength? One likely possibility is that, rather than aggregate LTCC activity being the cellular 
readout of neural activity, perhaps the combinatorial signaling through both CaV1.2 and CaV1.3 
LTCCs, play important roles for homeostatic signaling during chronic changes in network 
activity. Our results suggest that CaV1.2 LTCC disruption may act as a trigger for increased basal 
synaptic strength, a resulting phenotype that cannot be compensated for by signaling through 
other Ca2+ sources. Our data also suggest the possibility that CaV1.3-mediated signaling plays a 
positive regulatory role during HSP since CaV1.3 deletion disrupted upscaling without altering 
basal synaptic properties. However, since TTX-dependent upscaling is also occluded in 
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hippocampal neurons lacking CaV1.2, this homeostatic regulatory role may not be exclusively 
mediated by CaV1.3 LTCCs. It is important to consider that the “occlusion” of upscaling we 
observed in CaV1.2 lacking neurons may, in part, be due to a ceiling effect attributable to the 
increased basal mEPSC amplitude. This possibility seems unlikely given that mEPSC amplitudes 
exhibit a wide dynamic range (~5-80pA) and the average basal mEPSC amplitude observed in 
CaV1.2 cKOs (<20pA) is within the lower end of this range. Additionally, work in other genetic 
models have documented larger changes in basal mEPSC amplitudes that still exhibit robust 
homeostatic upscaling in response to chronic silencing with TTX (McCartney et al., 2014). 
Another important variable that may play a role in distinguishing CaV1.2 and CaV1.3 knockout 
effects on HSP is the spatial distribution of the two LTCC subtypes within hippocampal neurons. 
CNC1 and CND1 antibody immunoreactivity within the hippocampus demonstrated region-
specific expression of both CaV1.2 (CA1: cell body only; CA2/3: cell body and dendrites; DG: 
dendrites only) and CaV1.3 (cell body and dendrites throughout the hippocampus) (Hell et al., 
1993). The mixed hippocampal neuron cultures in our experiments do not exclude potential 
spatial distribution effects of CaV1.2 and CaV1.3 during homeostatic synaptic adaptations. Future 
experiments, possibly with chemo-genetic approaches that can be used to specifically disrupt one 
LTCC subtype at specific hippocampal regions, are needed to validate the roles of individual 
LTCC subtypes in HSP. 
 LTCCs are localized to somatodendritic domains of neurons and gate calcium influx in 
response to relatively large depolarizations in membrane potential. As such, they have long been 
though to play a critical role in decoding sustained changes in neuronal activity necessary for 
synaptic scaling. Of relevance, chronic hyperactivation can have differential effects of CaV1.2 
and CaV1.3-driven signaling owing to their different activation thresholds; CaV1.2 requires larger 
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depolarizing shifts relative to CaV1.3 (Helton et al., 2005).  Studies using double KO or gain-of-
function overexpression of CaV1.2 and CaV1.3 will be important in elucidating how alterations in 
LTCC expression affect HSP in neurons. It is also important to note that in each of our genetic 
systems, CaV1.2 and CaV1.3 were removed from both excitatory and inhibitory neurons. Future 
studies should explore the potential unique roles of each LTCC subtype in excitatory and 
inhibitory neurons, to determine whether homeostatic scaling of mEPSCs reflects action in 
excitatory neurons. A related question worth exploring is whether CaV1.2 and CaV1.3 play 
similar roles in the homeostatic scaling of inhibitory synapses. 
 Our work now opens up a framework to explore how LTCC subtypes each contribute to 
downstream effectors that regulate transcription or other processes needed to induce functional 
changes during synaptic scaling. One attractive potential effector is CaMKIV, a nuclear 
downstream signaling protein that encodes Ca2+ signals during activity perturbations and is 
known to be required for synaptic scaling (Goold & Nicoll, 2010; Joseph & Turrigiano, 2017). 
Finding overlaps in transcriptional programs with RNA-seq between CaV1.2 and CaV1.3 KO 
may also shed light on downstream gene products that are LTCC-mediated and required for 
homeostatic adaptations to alterations in network activity. 
 
Physiological implications of homeostatic resetting? 
The study outlined in Chapter 2 describes the fundamental role of a specific LTCC 
subtypes in TTX-dependent of mEPSCs (Figure 2.1B, 2.3B) and surface synaptic AMPAR 
expression (Figure 2.2F). Like virtually every other study in the homeostatic synaptic plasticity 
field, these experiments focused on mechanisms required during the induction of synaptic 
scaling. Given the presumed pervasive role of homeostatic signaling in stabilizing activity over 
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the lifetime of a neural circuit, there has been a general assumption that these processes can be 
recruited iteratively in circuits to buffer destabilizing patterns of activity at different times. 
However, whether such homeostatic adaptations in previously scaled networks can be repeatedly 
induced in the future has never been empirically tested. In fact, we describe experiments in 
Chapter 3 that indicate a “resetting” of scaled synaptic weights when network activity returns to 
basal levels, a widely presumed feature of synaptic scaling that has surprisingly never been 
demonstrated. The most relevant work on this issue came from Ehlers (Ehlers, 2003), who 
documented opposing and reversible changes in numerous PSD proteins upon chronic TTX or 
BIC treatment and drug washout in cortical neurons. His results imply a “resetting” like process 
at the level of protein expression, but no previous study has demonstrated that such a process 
occurs at the level of functional changes in synaptic strength. 
 Our work provides the first direct evidence that suggests that scaled synaptic weights, can 
be reset upon renormalization of network activity. While these findings are not surprising, they 
do underscore the notion that synaptic scaling can be temporally dissected into functionally 
distinct phases similar to Hebbian forms of plasticity; LTP can be partitioned into at least two 
phases, E-LTP and L-LTP (Huang, 1998). Moreover, as discussed in more detail below, these 
observations also raise questions about how the resetting phase of synaptic scaling impacts 
functional properties of the network. It is also relevant to consider that the induction phase of 
homeostatic scaling alone may also encapsulate distinct phases defined by unique molecular 
footprints that are needed in different time domains to instantiate homeostatic synaptic 
adaptations. The concept that temporal phases can be distinguished based on distinct biochemical 
interactions exists for LTP. It is generally thought that Ca2+ signaling through NMDARs and 
subsequent activation of Ca2+-dependent kinases such as CaMKs play crucial roles in the initial 
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induction of LTP but de novo gene transcription and protein translation is required for L-LTP 
(Frey et al., 1988). Further research is needed to evaluate whether similar molecular checkpoints 
exist during homeostatic synaptic scaling, but recent research from our lab is consistent with this 
possibility. Our unpublished studies reveal that the transcriptional coactivator and histone H3 
lysine 4 (H3K4) methyltransferase, KMT2A, plays a key role in regulating a secondary round of 
gene expression changes needed for synaptic downscaling. Curiously, however, KMT2A is 
required for downscaling during only the first 4hrs of network hyperactivation, indicating a time-
dependent transition in the mechanistic underpinnings of this form of homeostatic scaling 
(Tsukahara, Chen, Iwase, and Sutton, unpublished data). 
 
Is there a functional role for history-dependent suppression of synaptic scaling? 
As discussed earlier, homeostatic scaling is thought to functionally complement Hebbian 
forms of plasticity in neural circuits, but these two forms of plasticity typically act on vastly 
different time scales. We initially hypothesized that circuits may implement scaling mechanisms 
more rapidly if they have a prior history of synaptic scaling. This would allow for more efficient 
coordination between Hebbian and homeostatic forms of plasticity in neural circuits for both 
information storage and stability. However, our results actually demonstrated the opposite – a 
history of synaptic up- or down-scaling in hippocampal cultures, not only failed to accelerate 
future scaling events, but rather suppressed those homeostatic adaptations. This history-
dependent suppression was evident for both upscaling and downscaling and most intriguingly, 
future scaling was suppressed regardless of whether the initial event was in the same or opposite 
direction. We confirmed this refractory mechanism requires an initial scaling induction event as 
an acute (4hr) silencing of neurons with TTX, insufficient for scaling, had no appreciable 
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inhibition of scaling after resetting (Figure 3.4C). Interestingly, we demonstrated robust cLTP of 
mEPSC amplitudes in previously upscaled neurons suggesting the suppression of scaling does 
not generalize to all forms of synaptic plasticity (Figure 3.4H). Our data thus suggest that 
hippocampal neurons that have recently undergone scaling, enter a novel state that renders them 
refractory to homeostatic scaling of synaptic strength. A key question that now arises is whether 
other local forms of HSP driven by changes in synaptic drive (Sutton et al., 2006; Frank et al., 
2006; Jakawich et al., 2010), or a homeostatic adaptation in intrinsic excitability (Zhang & 
Linden, 2003; Marder & Goaillard, 2006), are also subject to history-dependent regulation. In 
particular, if local forms of HSP are similar inhibited by a previous history of synaptic scaling, 
this would reveal potential master homeostatic regulators and mechanistic cross-talk between the 
homeostatic signaling pathways tuned to global (firing rate) and local (synaptic drive) features of 
neuronal activity. 
 What features of homeostatic scaling confer the history-dependent suppression of future 
events? While this remains an open question, our data do point to a critical role for the resetting 
phase. Extending the resetting period from 48hrs to 96hrs eliminates history-dependent 
suppression indicating a finite lifetime of the homeostatic “refractory” period. Even more telling, 
removing the resetting phase altogether, by switching directly from network hyperactivation to 
suppression without an intervening reset period, also eliminates history-dependent suppression of 
synaptic scaling. Together, these findings implicate a key role for the resetting phase of synaptic 
scaling in suppressing future homeostatic scaling in the same network. The full functional 
implications of this relationship are still unknown. The suppression could reflect some 
incompatibility between “scaled” and “resetting” synaptic states, where the process of initiating a 
resetting program actively turns off homeostatic signaling pathways and/or transcriptional 
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regulatory events. Perhaps a deeper question is what functional role, if any, does this history-
dependent suppression confer? This too remains an open question, but one interesting possibility 
is that history-dependent suppression acts as a check on potential “runaway” homeostatic 
adaptations, where compensatory adaptations might overcorrect and bring the system into a 
potential pathological state. In response to cortical denervation, for example, some studies have 
demonstrated epileptic-like activity surrounding the damaged region, possibly due to 
homeostatic overcompensation in response to the initial insult (e.g., Paz et al., 2010; Takahashi 
et al., 2016). By suppressing a potentially additive homeostatic scaling response, resetting-
induced suppression of synaptic scaling may be a check on such potential pathological instances 
of overcompensation in neural circuits. 
 
What can genomics and proteomics reveal about functional homeostatic adaptations during 
synaptic scaling? 
It is now evident that activity patterns required for synaptic scaling have profound effects 
on gene transcription and translation. As noted earlier, the transcriptional profile of RAI1 
knockdown neurons closely resemble the transcriptional program driven by decreased network 
activity (Garay et al., 2020). Additionally, loss of RAI1 increased basal synaptic strength and 
inhibited upscaling but had no effect on downscaling of mEPSCs (Garay et al., 2020). A 
proteomic study using dynamic SILAC labeling in combination with mass spectrometry 
demonstrated a reduction in both protein degradation and protein synthesis during TTX-
upscaling and BIC-downscaling relative to control (Dörrbaum et al., 2020). Interestingly our 
BrU-seq experiments demonstrated that there were more TTX responsive downregulated genes 
than upregulated genes in both naïve and previously upscaled neurons (Figure 3.7C), a finding 
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consistent with other RNAseq studies (Benevento et al., 2016; Yu et al., 2015; Garay et al., 
2020). These studies suggest an overall downregulation in activity-dependent transcription 
during synaptic upscaling, but it is important to distinguish this profile from a generalized 
suppression of transcription. In addition to downregulated genes, several genes show specific 
upregulation during chronic activity silencing suggesting a more complex regulation of gene 
expression. Interestingly, we find that a history of synaptic scaling suppresses response to both 
up- and down-regulated TTX response genes, in addition to other dysregulated features such as 
incomplete recovery. Our gene ontology analysis reveals that these genes encompass several 
distinct functional categories – including voltage-gated cation channels, protein serine 
phosphatases, and trans-synaptic signaling regulators. Future studies will be needed to test the 
functional roles for specific subsets of this regulated pool. 
 
Final thoughts and future directions 
Over the past two decades, our understanding of homeostatic synaptic plasticity has 
increased exponentially with a particular intensive focus on the underlying molecular 
mechanisms of its induction. The study in Chapter 2 makes an important contribution in defining 
unique roles for CaV1.2 and CaV1.3 LTCC subtypes in its induction mechanism. However, our 
study outlined in Chapter 3 reveals that there is a considerable knowledge gap in our 
understanding of the temporal dynamics of synaptic scaling, beyond its induction. Our studies 
have revealed a novel resetting phase that alters the rules of future homeostatic scaling events. 
Future studies aimed at these complex aspects of activity-dependent homeostatic mechanisms are 
needed for a more complete understanding of network dynamics and maintenance of stability 
within the healthy brain. Insights from this basic knowledge will also lead to a better 
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understanding of neurological and neuropsychiatric disorders and potentially help efforts to 
develop novel therapeutics. 
 A crucial challenge for the field going forward is to better understand how homeostatic 
mechanisms operate within intact neural circuits in vivo. Although there is general agreement, 
from in vitro studies and theoretical models, that synaptic scaling is required for maintaining 
functional networks, we lack a clear understanding of how aberrant circuit dynamics are buffered 
by homeostatic synaptic scaling and other forms of homeostatic plasticity. For example, we do 
not y et know how different classes of homeostatic plasticity work together to stabilize network 
activity or even if they can be simultaneously expressed in the same synaptic sites in vivo. 
Despite that, evidence of synaptic scaling in several in vivo model systems (e.g.: visual cortex, 
Keck et al., 2013; motor cortex, Knogler et al., 2010; embryonic spinal cord, Garcia-Bereguiain 
et al., 2013; barrel cortex, Jamann et al., 2021) has emerged and this plasticity does share several 
important features with synaptic scaling studied in in vitro systems. The challenge now is to 
understand how more subtle changes in neural activity, rather than the extreme cases that have 
been studied to date, engage homeostatic signaling pathways in the context of dynamic neural 
circuits. With the rapid advancement of experimental tools capable of detecting and monitory 
neuronal activity with high spatial and temporal resolution (Ca2+-imaging, multi-electrode arrays, 
iGluSnfr, and genetic voltage indicators), there will be improved methods to forge the link 
between activity and HSP in behaving animal systems. Ultimately, continued efforts in 
identifying homeostatic adaptations during experience-dependent changes in neural activity will 
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